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Introduction: Mental disorders encompass a wide range of mental and behavioural conditions with a 
varying degree of symptom severity (mild, moderate and severe), onset, course (episodic, clusters of 
attack and chronic), and impact on afflicted individuals. Mental disorders affect about one in five people 
worldwide at any one point in their life. The aim of the research presented in this thesis was to establish 
estimates of the prevalence of mental disorders in Uganda and differentiate prevalence in both children 
and adults. 
Methods: The methods presented in this thesis adhere to JBI methodology and international standards 
for the conduct of a systematic review. Chapter 2 presents the a priori protocol for the conduct of the 
systematic review; Chapter 3 presents the final systematic review with meta-analysis of prevalence. A 
comprehensive search for studies conducted in the last 10 years was performed across five electronic 
databases and grey literature sources. All eligible studies were critically appraised and relevant data 
extracted. Prevalence estimates from included studies for the overall population, children and adults were 
pooled statistically. Certainty of the findings of the review was assessed using the Grading of 
Recommendation, Assessment, Development and Evaluation approach. 
Results: The search returned a total of 632 records, of which 26 articles published from 24 unique studies 
conducted in Uganda, involving 3,803 child and 14,091 adult participants were included in the review. 
Most studies assessed mental disorders mapped to the Diagnostic and Statistical Manual of Mental 
Disorders, fourth edition (DSM-IV), using valid instruments. Overall and with moderate level of certainty, 
the prevalence estimate of any mental disorders in Uganda was 22.9% in children and 24.2% in adults. 
The most prevalent disorder was depressive disorders, including major depressive disorders (22.2% in 
children and 21.2% in adults), followed by anxiety disorders (14.4% in children and 20.2% in adults), 
including predominantly posttraumatic stress disorder and generalised anxiety disorder. Eating disorder 
and psychotic syndrome disorder were also reported. 
Conclusion: Despite expected, significant heterogeneity, the results of this research show that about one 
in four persons in Uganda experience mental disorders. The findings also reveal the paucity of 
epidemiological studies investigating range of mental disorders in Uganda. Further countrywide 
epidemiological studies of mental disorders are required to explore prevalence of other mental disorders 
and its associated factors not captured by the present research, with increased sample sizes among 
children. The findings also highlight important health policy and practice applications to address the 






I, John Nelson Opio, certify that this work contains no material which has been accepted for the award of 
any other degree or diploma in my name, in any University or other tertiary institution and, to the best of 
my knowledge and belief, contains no material previously published or written by another person, except 
where due reference has been made in the text. In addition, I certify that no part of this work will, in the 
future, be used in a submission in my name, for any other degree or diploma in any University or other 
tertiary institution without the prior approval of the University of Adelaide. 
I acknowledge that copyright of published works contained within this thesis resides with the copyright 
holder(s) of those works. 
I also give permission for the digital version of my thesis to be made available on the web, via the 
University’s digital research repository, the Library search and also through web search engines, unless 
permission has been granted by the University to restrict access for a period of time. 
I acknowledge the support I have received for my research through the provision of an Australian 
Government Research Training Program Scholarship 
John Nelson Opio 
October 2020 
 
The Graduate Centre 












This thesis reflects the incredible support and encouragement from several individuals and institutions. 
In particular, I would extend my sincere appreciation to: 
Associate Professor Edoardo Aromataris, my principal supervisor, for your long, sincere and enduring 
support and encouragement from the very beginning to the completion of this thesis. Thank you for your 
unwavering patience throughout this academic journey. 
Associate Professor Mukdarut Bangpan, my co-supervisor, who graciously accepted to join my 
supervisory panel, your timely feedback and your inspiring support within the short timeframe. 
Associate Professor Zachary Munn, for your constructive guidance, capacity building in systematic 
reviews and assistance with software for meta-analysis and assessing certainty in evidence. 
Associate Professor Craig Lockwood, Postgraduate Coordinator, for your support that went beyond the 
confines of academia. 
Dr Catalin Tufanaru, my former co-supervisor, who played an instrumental role in shaping the theoretical 
framework that unpinned access to research in health services. 
Alex Migone, Higher Degree by Research Program Coordinator, for ensuring that all my communication 
and documentation required by The Graduate Centre were processed in a timely manner. The teams 
within JBI in ensuring my articles met journal requirements, particularly, Sarah Silver and Effie Minnema, 
for being there whenever I was stuck in one way or the other. 
The Women’s and Children’s Hospital management and staff working at Michael Rice Ward, for the care 
and support for my son, in particular, Dr Monika Pal, Dr Sharon, Dr Malaika, Dr Michael and Consultant 
Nurse Anne Jackson. 
The Ugandan Community of South Australia, for giving the mandate and support to exercise my 
leadership skills; Regency Park Rotary Club, for your gracious support and engagement; Housing 
Choices for providing me with affordable accommodation; and David King, my neighbour, for your 
company and for simply being there. 
Siew Siang Tay, who undertook professional copyediting of this thesis in accordance with the Australian 
Standards for Editing Practice (specifically Chapter 1 and Chapter 4) in a timely manner. 






List of abbreviations 
ADF  Allied Democratic Front  
ADHD  Attention Deficit Hyperactive Disorder 
AIDS  Acquired Immune Deficiency Syndrome 
ART  Antiretroviral therapy  
BDI  Beck Depression Inventory 
C$  Canadian Dollar 
C.I  Confidence interval  
CDDG  ICD-10 Clinical Descriptions and Diagnostic Guidelines 
CDI  Children’s Depression Inventory  
CES-D  Centre for Epidemiologic Studies Depression Scale 
CHD  Coronary heart disease 
DALYs  Disability- adjusted life years 
DHSCL-25 Hopkins Symptom Checklist, depression module (15 items) 
DPC  Depression pain comorbidity  
DSM  Diagnostic and Statistical Manual of Mental Disorders 
DSM-5  Diagnostic and Statistical Manual of Mental Disorders fifth edition 
DSM-IV Diagnostic and Statistical Manual of Mental Disorders fourth edition 
EPDS  Edinburgh Postpartum Depression Scale  
GAD  Generalised anxiety disorder 
GAD-Q-IV Generalised Anxiety Disorder Questionnaire for DSM IV 
GBD  Global Burden of Disease study 
HIV  Human Immunodeficiency Virus  
HSCL-25 Hopkins Symptom Checklist 25 items for anxiety and depression 
HTQ  Harvard Trauma Questionnaire  
I2  Heterogeneity statistic 
ICD-10  International Classification of Disease and Related Health Problems 10th revision 
x 
 
ICD-11  International Classification of Diseases 11th revision 
ICD-TQ  ICD-11 Trauma Questionnaire 
IDP  Internally displaced persons 
JBI  The Joanna Briggs Institute 
LMIC  Low- and Middle-Income Countries 
MDD  Major depressive disorder 
MFQ-C  Short Mood and Feelings Questionnaire-Child Self Report 
MINI Kid Mini International Neuropsychiatric Interview for children and adolescents 
MINI  Mini International Neuropsychiatric Interview  
PDS  Posttraumatic Diagnostic Scale 
PHQ  Patient Health Questionnaire 
PHQ-9  Patient Health Questionnaire 
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
PTSD  Post-traumatic stress disorder 
SCARED  5-item version of the Screen for Child Anxiety Related Disorders  
SCID  Structured Clinical Interview for DSM-IV 
TSCC  Trauma Symptoms Checklist for Children  
UNICEF United Nation Children’s Fund 
UPID  University of California at Los Angeles PTSD Reaction Index for DSM-IV 
VSLA  Village Savings and Loan Associations 
WHO  The World Health Organization 
YLD  Years lived with disability 
YLL  Years of life lost 
1 
 
Chapter 1 Introduction and background 
1.1 Introduction 
Uganda faces dual epidemiological challenges of communicable and non-communicable diseases. 
Considering the burden of disease, the morbidity due to non-communicable diseases like mental 
disorders is rapidly overtaking common communicable diseases, such as malaria and human 
immunodeficiency virus/acquired immunodeficiency disease syndromes (HIV/AIDS) as well as common 
childhood illnesses such as diarrhoea.1,2 The burden of mental disorders in Uganda and countries in Sub-
Saharan Africa is projected to grow exponentially as a result of demographic changes, economic 
development, changing natural environments and human displacement, among others.3 Yet, mental 
disorders appear to be a neglected public health priority, as evidenced by the scarce and inequitable 
distribution of resources such as funding and lack of health professional workforce proportionate to its 
burden.4 The diverse and evolving nature of this dual disease burden necessitates a shift in current 
healthcare responses. To address this need, research evidence is required to underpin policy and 
practice decisions in order to tackle mental disorders as well as physiological ailments. Evidence such as 
the prevalence of mental disorders and use of mental health services in Uganda is currently lacking or 
fragmented. The conceptualisation of this thesis was an attempt to address such gaps through a 
systematic review of research quantifying mental disorders in the Ugandan context. 
This chapter provides the context for this thesis on the broad subject of mental disorders. It provides: the 
definition and classification of mental disorders; specific diagnostic criteria and prevalence of some 
commonly diagnosed mental disorders; the health, social and economic impact of mental disorders; and 
the cause, risk factors and research context of mental disorders in Uganda. This chapter concludes with 
the objectives, research questions and introduction to the research methodology used: the systematic 
review. To facilitate the reading of this thesis, a glossary of abbreviations or acronym is provided at the 
beginning. 
1.2 Health, mental health and mental disorders 
The World Health Organization (WHO) in its 1946 constitution (Amendments adopted in 2006) defined 
health as a state of complete physical, mental and social wellbeing and not merely the absence of disease 
or infirmity.5 ‘Mental health’ and ‘mental disorders’ are frequently used terms and often used 
interchangeably to infer emotional or cognitive problems, however their meaning is far from being 
universally accepted.6 Empirical evidence indicates that mental health and mental disorders are not 
opposite ends of a single continuum, and the absence of mental disorders does not equal the presence 
of mental health.7 According to the WHO, mental health is defined as a state of wellbeing in which the 
individual realises his or her own abilities, can cope with the normal stresses of life, can work productively 
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and fruitfully, and is able to make a contribution to his or her community.8 Mental health is therefore a 
fundamental aspect of an individual’s wellbeing.5 However, for some individuals, the desired state of 
mental health can be disrupted at some point in their lives.9 The remainder of this introductory chapter 
explores the existing literature on what is known about mental disorders globally, regionally and in Uganda 
to set the scene for the chapters that follow (see Chapter 2 and Chapter 3). 
Traditionally, people with disrupted mental health or behaviours have been labelled using a variety of 
terms, for example, mad, possessed, insane, lunatic and crazy.10,11 In Uganda, and perhaps in many 
other cultures, deviations from a normal state of mental health are described differently, for instance, the 
Baganda ethnic group use eddalu to describe representation of a violent madness or akazoole to describe 
schizophrenia.12 These labels convey negative connotations that may trigger or increase stigma and 
social isolation for the individual affected.11 Similarly, in clinical disciplines and research, a variety of terms 
are used to broadly describe mental health problems, such as mental illness, mental disorders, psychiatric 
conditions and psychopathology, which are often used interchangeably to accommodate perspectives of 
people with different theoretical views about the aetiology of mental health conditions.13 Differences in 
terminology highlight current complexities in the diagnosis of mental disorders and the perceived need or 
preference for some types of management and treatment to improve for mental health. The breadth and 
depth of lay and professional views, and the bases for labelling of mental health problems are beyond the 
scope of this thesis. Therefore, throughout this thesis, the term mental disorders will be used in its 
broadest sense. 
The term mental disorders have been used by mental health experts to imply the existence of a syndrome 
characterised by clinically significant disturbance in an individual’s cognition, emotion regulation or 
behaviour that reflects a dysfunction in the psychological, biological or developmental processes 
underlying mental functioning.14,15 Mental disorders are usually associated with significant distress or 
disability affecting individual, social, occupational or other important activities. The functional impairment 
or significant distress or disability due to mental disorders refers to the amount of disruptions it causes to 
individual, social (such as getting along with people, domestic life), occupational (education, employment, 
community and civic life), or other important activities (including self-care and communication).16 This 
definition provides a general framework for the important aspects of diagnosing a mental disorder, 
namely, the level of disturbance experienced by an individual should be significant enough to disrupt their 
ability to cope with stressors and, work or to relate effectively with others.17 It also provides the basis for 
which distress or behaviours can be excluded from a mental disorder diagnosis. For instance, expected 
behaviours or culturally appropriate responses to a common stressor such as the death of a loved one, 
or loss, are not mental disorders.15 A further exclusion is socially deviant behaviours such as those 
instigated by political, religious or sexual motives, and conflicts that are primarily between the individual 
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and society, unless such deviance or conflict occurs due to a dysfunction in an individual.14,15 However, 
the lack of precision provided by the definition of mental disorders has fuelled further debate, both for 
clinical practice and research. For example, the concept of ‘dysfunction’, though universally used, has 
been a contested parameter for which to assess mental disorders as ‘dysfunction’ and needs to be better 
defined.18  
1.3 Burden of mental disorders 
It is now widely recognised that individuals with mental disorders can experience a high level of disability 
for prolonged periods and are likely to die prematurely.9,19 To quantify the burden attributable to a specific 
disease in a population, disability adjusted life years (DALYs) is a frequently used health metric.20 The 
DALYs was first introduced as a summary measure of state of health of a population in the Global Burden 
of Disease study (GBD).20 Disability adjusted life years are defined as the sum of years of life lost (YLL) 
and years lived with disability (YLDs) due to a disease or health condition.20,21 One DALY represents one 
lost year of healthy life.22 
The GBD 2010 was the largest systematic assessment of the descriptive epidemiology of diseases and 
injuries.23 Analysis of the GBD 2010 data consistently highlights that mental disorders are a major 
contributor to DALYs and the leading cause of YLDs globally. According to the GBD 2010, mental, 
behavioural and substance use disorders contributed 183.9 million (7.4%) of DALYs from all the 291 
diseases and injuries evaluated.24 These DALYs comprise 8.6 million YLLs (about 232 thousand deaths) 
and were the leading cause of non-fatal burden of disease, accounting for 175.3 million (22.9%) YLDs.24 
25 Of the 20 specific mental disorders that were assessed,24 depressive disorders were the leading cause 
of DALYs, accounting for 74.3 million (40.5%) DALYs;24 this was followed by anxiety disorders (26.8 
million: 14.6%), schizophrenia (13 million: 7.4%), bipolar disorder (12.9 million: 7.0%), pervasive 
developmental disorders (7.7 million: 4.2%), childhood behavioural disorders (6.2 million: 3.4%) and 
eating disorders (2 million: 1.2%).24  
However, the burden of mental disorders based on the GBD 2010 has been criticised for its 
methodological limitations.26 Critics argue that the arbitrary separation of psychiatric and neurological 
disorders, the differentiation of suicide and intentional self-harm as a separate category from mental 
disorders, the exclusion of personality disorders from the analysis, the allocation of somatoform 
syndromes in total to musculoskeletal disorders, and inadequate consideration of the contribution of 
severe mental disorders to the other causes of mortality all represent significant constraints on the 
accuracy of estimation provided by this study.26 Other authors suggest that the disease burden 
attributable to mental disorders is much higher than the global burden of mental disorders reported in 
2013,24 suggesting the true burden of mental disorders from the GBD 2010 data was 233.7 million (13.0%) 
DALYs and 32.4% YLDs.26 
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Evidence suggests that the burden of mental, neurological and substance use disorders also varies by 
type of disorder, geography, age and gender.19 It has been reported that mental disorders are the largest 
contributor to DALYs due to mental, neurological and substance use disorders.25 Mental disorder’s share 
of DALYs due to combined mental, neurological, and substance use disorders was 56.7%, followed by 
neurological disorders (28.6%) and substance use disorders (14.7%).25 The burden of mental disorders 
also varies by world region, disproportionately affecting people living in low- and middle-income countries 
(LMICs, as classified by the World Bank27).19,28 According to the WHO global estimates of burden and 
prevalence of depressive, anxiety and other common mental disorders (2017), an estimated 80% of the 
burden of mental disorders experienced globally occurs in people living in LMICs.19 In Sub-Saharan Africa 
(SSA), the DALYs due to mental and substance use disorders are estimated at 21.5 million and are 
predicted to grow by 130% to 45 million YLDs between 2010 and 2050, driven by population growth and 
ageing.3 The greatest burden of mental disorders is said to occur among young people under 30 years of 
age 24 and in women.25 
In Uganda, it was estimated that 10.5% (332,539) of total YLDs were attributable to depressive disorders 
and another 3.1% (99,558) YLDs were due to anxiety disorders in 2015.19 This makes Uganda the country 
most affected by the burden of mental disorders in the WHO African region,19 although it must be noted 
that these estimates are based on very limited data from LMICs.29,30 
Although mental disorders are frequently not considered a direct cause of death, research invariably 
suggests that they cause a considerable impact to individuals, families and society.28 These impacts may 
vary for individuals but in general they are related to individual health, and social and economic status 
which are not included in DALYs that focus on loss of health.23 Therefore, the implications of GBD findings 
by policy makers in mental health can be enhanced by understanding the impact of mental disorders on 
the family, society, economy and social services. 
1.4 Impact of mental disorders 
The distress, dysfunction and disability engendered by mental disorders do not only affect the individual 
with the affliction, but also their family, the society in which they live, and economic productivity in 
general.28 
1.4.1 Health impact of mental disorders 
Researchers have invariably reported that people with mental disorders have poorer health outcomes 
than the general population, attributable to shorter life expectancy due to unnatural causes, suicides and 
disability that lead to poor quality of life.31-33 Research from high income countries shows that people with 
mental disorders are likely to die 10 to 20 years earlier than the general population 31 and higher rate 
have been reported in countries in SSA.33 The most common causes of these deaths are attributable to 
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untreated or under treatment of physical ailments such as HIV, coronary heart disease (CHD), cancer 
and diabetes.31-33 Mental disorders have also been reported to lead to suicide.28 Mental disorders such 
as anxiety and depressive disorders also affect the incidence of other chronic conditions as they increase 
risky behaviours such as smoking and addictive substance use.28,34  
1.4.2 Social impact of mental disorders 
The early age of the onset of mental disorders has the potential to affect an individual’s education and 
future career. Research shows that young adulthood is a particularly important period as it is a period 
when an individual’s discovery of identity and self occurs.35 It is also a period during which they are 
undergoing an education, starting a family (marriages), or commencing employment.36 Individual 
aspirations and developmental changes during adolescence can be adversely affected by mental 
disorders. 
A systematic review of social impact of severe mental illness from LMICs (including Uganda, Nigeria and 
Thailand) identified poor physical health and increased psychological problem among family members, 
that affected their quality of life.37 The same review also reported higher divorce rates, fewer marriages, 
poor family cohesion and strained family environment as direct impact of a mental disorder.37 In addition, 
the review also shows that children of parents affected by mental disorders are more likely to develop 
psychiatric problems, poorer school performance and level of functioning.37 
Poor school performance  and failure to complete high school education  by young people has also been 
reported by a national comorbidity survey in the United States.38,The authors specifically reported that 
anxiety disorders, depressive disorders and bipolar disorders are the common disorders associated with 
the reasons young people fail to complete high school education.38 These findings suggest a considerable 
contribution of mental disorders to diminished educational attainment occurring at a young age. 
Mental disorders have also been shown to reduce the individual’s self-esteem, their capacity to 
communicate effectively and their ability to maintain social relationships.28,39 Research shows that major 
depressive, bipolar, anxiety and substance use disorders have been associated with relationship 
instability and is a major cause of divorce and separation.40 Moreover, mental disorders manifesting as 
lack of affection, inconsistent enforcement of rules and also bad parenting have been shown to negatively 
impact on a child’s cognitive and emotional development.41 
1.4.3 Economic impact of mental disorders 
A considerable body of literature assessing the economic burden of mental disorders exists. Economic 
impacts range from loss of productivity at an individual level due to impaired functioning to healthcare 
costs which transfer cumulatively to a societal level.42,43 For example, a survey of adolescents concluded 
that young adults who had high-stable trajectories of mental disorders from the age of 11 to 19 were at 
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risk of poor employment outcomes.44 The study showed that people who had mental disorders during 
that age period (11-19) were likely to work without basic education, have left school, not be employed or 
not undertaking training by the age of 19 years.44 Furthermore, findings from the National Comorbidity 
Survey (NCS) in the United States indicated that people who had mental disorders such as major 
depressive, bipolar or anxiety disorders were more likely to be laid off from employment or remain 
unemployed.45  
A study conducted in Europe estimated the cost of depression at 118 billion Euro, or 253 Euro per person 
in 2004.46 Of these, direct costs for drugs and hospitalisation accounted for 42 billion Euro and indirect 
costs 76 billion Euro.46 Another study conducted in Canada found that the healthcare cost for a person 
with mental disorders was C$31,611, compared to C$23,681 for those without mental disorders.47 
Research also shows that people most affected with economic burden, skewed toward those who are 
younger, live in poorer neighbourhoods and have different patterns of health care utilisation.47 
In LMICs, a systematic review identified economic consequence of mental disorders including financial 
strain, increase costs related to care, loss of productivity, cost of treatment of side effects and reduced 
ability of family members to perform regular activities (time to give care to the patient).37 The same review 
also documented the long-term economic drift and food insecurity as an effect of mental disorders.37 
Another review revealed that mental disorders such as anxiety and depression impact on decision making 
and risk taking that indirectly affect individual economic changes.48 
1.5 Classification of mental disorders 
Research suggests that mental disorders and the clinical features that a clinician could reasonably expect 
to encounter in all cases are included in two major classification systems of mental disorders.49 
Understanding the case definition of a specific mental disorder is important for its diagnosis and 
measurement of prevalence. A brief description of the two-classification framework of mental disorders is 
included in this section. 
The current major classification systems of mental disorders, the International Classification of Diseases 
and Related Health Problems (ICD) published by the WHO,14 and the Diagnostic and Statistical Manual 
of Mental Disorders (DSM) published by the American Psychiatric Association (APA),15 have evolved 
from years of expert opinion and research.50 The purpose of the standardised classification of mental 
disorders is to enable clinicians to achieve better diagnostic agreement and improve communication, 





1.5.1 ICD-10 classification of mental and behavioural disorders: clinical descriptions and 
diagnostic guidelines 
Chapter V(F) of ICD-10, Classification of Mental and Behavioural Disorders: Clinical Descriptions and 
Diagnostic Guidelines (CDDG), contains codes of up to six characters long to classify a wide variety of 
signs, symptoms and abnormal feelings of social circumstances.14 According to this classification system, 
mental disorders are clustered into ten blocks (F00-F99) on the basis of their common features.14 The 
blocks F00 to F99 and list of mental disorders are presented in Table 1.1 below. It is worth noting here 
that the number of specific disorders within each block in ICD-10 are numerous; only a few of the most 
commonly diagnosed disorders are examined further in the thesis and therefore have been included in 
Table 1.1 as examples. 
Table 1.1: List of mental disorders according to ICD-10 classification 
F00-F09 Organic mental disorders: dementia in Alzheimer’s disease, delirium not induced by alcohol, 
and personality disorders due to brain damage, and others 
F10-F19 Mental and behavioural disorders due to psychoactive substance use: disorders from use of 
alcohol, opioids, cannabinoids, sedatives, multi-drugs, volatile substances and others 
F20-F29 Schizophrenia, schizotypal and delusion disorders: psychotic disorders, whether acute or 
transient, schizophrenia and others 
F30-F39 Mood or affective disorders: manic episodes, bipolar affective disorder, depressive episodes, 
dysthymia, recurrent depressive disorders and others 
F40-F48 Neurotic, stress and somatoform disorders: phobic anxiety disorder, other anxiety disorders, 
obsessive compulsive disorder, post-traumatic stress disorder (PTSD), adjustment disorder, 
somatoform and others 
F50-F59 Behavioural syndrome associated with physiological disturbance and physical factors: eating 
disorders, non-organic sleep disorders, sexual dysfunction not caused by organic disorders and others  
F60-F69 Disorders of adult personality and behaviours: specific personality disorders (paranoid 
personality disorder, emotionally unstable personality disorder), mixed personality disorder and others 
F70-F79 Mental retardation and others: mild, moderate, severe, profound and other unspecified 
mental retardation 
F80-F89 Disorders of psychological development: developmental disorders of speech and language, 
disorders of scholastic skills, motor function disorder, pervasive developmental disorder and others 
F90-F98 Behavioural and emotional disorders with onsets usually occurring in childhood and 
adolescence: conduct disorder, separation anxiety disorder, social anxiety disorder, disturbance of 
activity and attention, tic disorder and others. 
F99  Unspecified mental disorders:  This is a reserved for mental disorders not otherwise specified 
and cannot be coded to category F00-F98. 
 




1.5.2 Diagnostic and Statistical Manual of Mental Disorders 
The Diagnostic and Statistical Manual of Mental Disorders (DSM), first published in 1952 (DSM-I), is 
another classification framework for mental disorders used in the United States and many countries 
around the world by psychiatrists and other clinicians, health insurance companies, psychiatric drug 
regulatory agencies, policy makers and researchers for mental health services and academic 
researchers.51 Authors of DSM-5 argue that any diagnosis of mental disorders should help clinicians to 
determine the prognosis, treatment plan and potential treatment outcome.15 A list of categories of mental 
disorders in DSM-5 15 are presented in Table 1.2 
Table 1.2: List of mental disorders categories according to DSM-5 classifications 
Neurodevelopmental disorders: intellectual disabilities, communication disorders (language disorders, 
speech disorders, childhood onset fluency disorder),  attention deficit hyperactive disorder, motor 
disorders and others 
Schizophrenia spectrum and other psychotic disorders: schizotypal disorder, brief psychotic disorder,  
schizophreniform disorder, delusional disorder and others 
Catatonia: Catatonia associated with another mental disorder and others 
Bipolar and related disorders: bipolar I disorder, bipolar II disorder and others 
Depressive disorders: major depressive disorder, persistent depressive disorder (dysthymia) and 
premenstrual dysphoric disorder, disruptive mood dysregulation disorder and others 
Anxiety disorders: separation disorder, selective mutism, specific phobia, social anxiety disorder, panic 
disorder, agoraphobia, generalised anxiety disorder and adjustment disorder and others 
Obsessive-compulsive and related disorders: obsessive-compulsive disorder, body dysmorphic 
disorder, hoarding disorder and others 
Trauma and stressor related disorders: reactive attachment disorder, post-traumatic stress disorder, 
adjustment disorder and others 
Dissociative disorders: dissociative identity disorder, dissociative amnesia, depersonalisation 
/derealisation disorder and others 
Somatic symptom and related disorders: somatic symptom disorder, illness anxiety disorder, factitious 
disorder and conversion disorder and others 
Feeding and eating disorders: pica, anorexia nervosa, bulimia nervosa, binge eating and others. 
Elimination disorders: enuresis, encopresis and others 
Sleep-wake disorders: insomnia disorder, breathing related sleep disorder and parasomnia and others. 
Sexual dysfunctions: delay in ejaculation, erectile disorder, female orgasmic disorder and others 
Gender dysphoria: gender dysphoria and other specified or unspecified gender dysphoria 
Disruptive, impulse-control and conduct disorders: oppositional defiant disorder, intermittent explosive 
disorder, pyromania, kleptomania, antisocial personality disorder and conduct disorder with onsets in 
childhood and adolescence and others 
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Substance related and addictive disorders: alcohol related disorders, cannabis related disorders, 
inhalant related disorders, opioids related disorders, stimulant related disorders and non-substance 
related disorders (gambling) and others 
Neurocognitive disorders: delirium, major and mild neurocognitive disorders and others 
Personality disorders: Cluster A personality disorders (paranoid personality disorder, schizoid 
personality disorder, schizotypal personality disorder) cluster B personality disorders (borderline 
personality disorder antisocial personality disorder), Cluster C personality disorders (avoidant 
personality disorder and dependent personality disorder) and others 
Paraphilic disorders: exhibitionistic disorder, voyeuristic disorder, paedophilic disorder, frotteuristic 
disorder and others 
Other mental disorders: unspecified mental disorders due to other medical conditions and others 
Source: Adapted from the Diagnostic and Statistical Manual of Mental Disorders DSM-5, American Psychiatric Association 201315  
1.5.3 Critique of the classification systems of mental disorders 
Although the operationalised diagnostic criteria in ICD and DSM reflect agreement in case definition, the 
lists of disorders in Table 1.1 and Table 1.2 reveal distinctive structural differences in the classification of 
mental disorders. One classic example is post-traumatic stress disorder (PTSD) which is grouped in F40-
F49 in ICD-10, along with anxiety disorders,52 whereas PTSD is in a separate block related to trauma in 
the DSM-5.15 Research has also identified differences in the formulation of disability in ICD and DSM; 
particularly notable is clinical significance not being a major requirement in ICD as it is in DSM.16 
Therefore it has been suggested that the DSM has a strong influence in both research and clinical practice 
because of its stricter symptom criteria than ICD-10.16 
Although the ICD and DSM have provided a necessary shared language for health professionals and 
research, they are not without limitations. Four main areas of criticism have been documented.53 These 
include the construct of categories and dimensions of disorders, symptom thresholds, and the aetiology 
(cause) and comorbidity of mental disorders as a complex concept in the understanding of diagnostic 
criteria or guidelines.53 The construct of categories and thresholds is briefly presented below. Comorbidity 
and cause will be addressed in Sections 1.8 and 1.9, respectively. 
1.5.4 Categories and dimensions 
Critics of DSM-5 note that the number of diagnosable mental disorders has increased substantially from 
128 when DSM was first created in 1952 to 541 in 2013 (DSM-5),51 hence posing difficulties for health 
providers to remember the diagnostic criteria for each disorder.51,54 It also highlights the lack of 
consistency in diagnostic criteria for mental disorders.53 Likewise, disorders are divided into a continuum 
of arbitrary categories, not singular distinct entities.55 However, the dimensionality of mental disorders 
presents problems in another respect, both conceptually and in practice. Critics argue that mental 
disorders are not distinct disorders but complex combinations of psychological problems, which 
themselves are dimensional. Clearly, reconciling the complex multidimensional nature of mental disorders 
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with the structure of these classification systems is a major challenge.53 Notwithstanding the questionable 
conceptual validity of current diagnostic categorisation, it has been shown to have high utility by virtue of 
their guidance on outcomes, treatment response and aetiology.55 
1.5.5 Thresholds 
Research suggests that the diagnosis of mental disorders can be a complex process of understanding 
symptoms, duration, exclusion criteria and clinical significance.56 However, it has been argued that clinical 
significance is key to assisting in the diagnosis of disorders as being “non-existent”, “mild”, “moderate” or 
“severe”, and in predicting the course of the disorders.56 A retrospective study that reviewed records of 
patients admitted due to episodes of depression in Denmark over a six-year period concluded that ICD-
10 grading of severity and use of symptom thresholds are clinically useful.57 The same study found that 
classifying the severity of depressive disorders as “mild” or “moderate” does not imply a diagnosis is not 
a serious condition.57 
Despite the lack of a clear distinction between specific mental disorders within a category and the 
emphasis on thresholds of clinical significance for symptoms in the ICD and DSM mentioned above, these 
manuals are widely accepted internationally by researchers and health professionals. They are known to 
provide a standard nomenclature for specific mental disorders and symptom clusters that are vital for 
clinical diagnosis, service provision and research application. For example, a survey of diagnostic criteria 
used to assess mental disorders by mental health professionals from 44 countries reported that 70% of 
respondents used ICD-10 and 23% solely used DSM-IV.58 However, evidence from a systematic review 
showed that most English-speaking countries tend to use DSM criteria for research.59 
1.6 Diagnosing mental disorders 
Assessment of mental disorders is based on recording accurate descriptions of an individual presentation 
of symptoms that have been experienced or are being experienced at the time of assessment, and 
observable behaviours. The operationalisation of diagnostic criteria has led to the development of 
assessment instruments with an improved reliability and validity to assess for specific mental 
disorders.17,60 Instruments to assess mental disorders fall under two main categories: diagnostic 
instruments and screening instruments.61 They can be administered by clinicians and, lay interviewers, 
or be self-administered by the individuals being assessed.61 
Diagnostic instruments, the use of which is also known as a schedule or examination, are designed to 
provide precise diagnosis of mental disorders based on specific symptoms described by diagnostic 
criteria (DSM or ICD) and are useful for clinical decision making.61 Diagnostic instruments can be fully 
structured, demanding the investigator or clinician to adhere to the specificity of the questions, or semi-
structured, allowing the investigator to probe for additional information.61 Diagnostic instruments are 
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designed to allow non-clinicians to conduct a fully- or semi-structured interview that is equivalent to 
psychiatric diagnoses.61 There are a number of diagnostic instruments validated for use in different 
settings. The Mini-International Neuropsychiatric Interview (MINI), a brief structured modular diagnostic 
interview used for the assessment of mental disorders, based on ICD-10, DSM-IV and DSM-5 criteria, is 
one example of a diagnostic instrument.62 MINI was developed by psychiatrists for the assessment of 
multiple mental disorders and has three different versions: MINI plus, MINI Screen and MINI for children 
and adolescents (MINI Kid).62 Other diagnostic instruments include the Structured Clinical Interview for 
DSM-IV (SCID), 63 and the WHO Composite International Diagnostic Interview (WHO-CIDI).61 
Screening instruments or symptom inventories (also known as dimensional instruments) are used to 
assess a wide range of specific mental disorders, usually by eliciting information about the presence or 
absence of symptoms, and the frequency and severity of symptoms during a specified timeframe.61 
Evidence indicates that most screening instruments are designed to measure only one or two specific 
disorders.61 Unlike diagnostic instruments, where diagnosis is discrete as ‘case’ or ‘no case’, screening 
instruments score symptoms on a continuum with a cut-off point to define cases or no cases.61 A further 
distinction is that screening instruments are only used to assess for current mental disorders.61 To 
maximise the applicability of screening instruments across cultures, validity needs to be assessed against 
a gold standard diagnostic interview conducted by a qualified mental health professional, preferably in a 
setting in which it is used.64 
As with diagnostic instruments, there are several instruments in this category. The nine-item Patient 
Health Questionnaire (PHQ-9),65 25-item Hopkins Symptom Checklist (HSCL-25),66 Centre for 
Epidemiologic Studies Depression Scale (CES-D)67 and Beck Depression Inventory (BDI)68 are some 
examples of screening instruments. A number of them have been assessed for appropriateness 
screening mental disorders, like depression and anxiety disorders, in low resource settings.69 These 
include the PHQ-9,65 with a cut-off score of 10 and above, which has been reported to provide acceptable 
discriminatory power to diagnose depression in adults.70,71 Another instrument used to assess both 
anxiety and depression disorders is the HSCL-25 Part I, which consists of 10 items to assess for anxiety 
disorders and Part II, a depression module consisting of 15 items (a cut-off score ≥1.75 is deemed to 
detect current major depressive disorders).66 A systematic review reported that there are several free, 
easily accessible, brief and validated instruments to assess a range of mental disorders in low-resource 
settings.78 These include multiple instruments to assess anxiety disorders, depression, disruptive 
behaviour disorders, eating disorders, mania, overall mental health, personality disorders, suicidality, and 
trauma in both adults and young people.69 
Research conducted in non-western cultures indicated that the diagnostic system72 and survey 
instruments73 can influence the estimation of prevalence across cultures.74 Literature indicates that most 
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of the instruments developed to assess mental disorders are based on a western-psychiatric context and 
suffer from different interpretations in different cultures.75 Research shows that a person’s response to a 
particular item in the assessment instrument is a direct reflection of their beliefs about mental disorders, 
their knowledge and social factors.61 For example, a systematic review that assessed cross-cultural 
validity of screening instruments in SSA reported that the manifestation and expression of symptoms of 
depression and anxiety disorders in African culture were inconsistent with the questions in the instrument 
developed in western cultures.76 The author concluded that any assessment of mental disorders should 
ensure the respondent understands the questions in the instrument in the intended way.76 It has been 
argued that the reliability of the assessment technique should take into consideration the study context, 
in addition to the diagnostic criteria, symptom thresholds, functioning and duration.77 
Previous research suggests that for a psychometric scale to be reliable and valid, it has to fulfil linguistic, 
content, conceptual, technical and criteria equivalence.78 Linguistic equivalence means that there is 
confidence in the translation of an instrument and that it retains meaning across multiple cultures, using 
back translation techniques.78 Content equivalence proposes that the items in a psychometric scale 
correspond to phenomena present across cultures. The conceptual equivalence means that the same 
underlying construct is being measured across cultures.78 Technical equivalence aims to ensure that the 
method of administration of the instrument is the same across cultures to eliminate instrument bias.78 
Criterion equivalence refers to a similar interpretation of the results across cultures in relation to the norm 
of each culture.78 This suggests the need for adapting instruments to the context of the research to ensure 
it is reliable and the results are valid.75 Nevertheless, it has been suggested that assessment of mental 
disorders, whether they take the form of interviews or symptom checklist questionnaires, can generate 
reliable prevalence estimates in a general population.15,61,79 
1.7 Diagnosis and prevalence of mental disorders 
As previously mentioned in Section 1.3, accurate prevalence data is needed to calculate the burden of 
disease and determine the needs of health services.80 Prevalence of mental disorders measures the 
proportion of individuals who manifest a specific mental disorder at a specified time or period.80 It is 
usually calculated by dividing the number of individuals who manifest a disorder as a numerator by the 
total population assessed, including those who manifest a disorder as a denominator, and is expressed 
as a percentage or number of people per 1,000 population.80 Typically, mental disorders are estimated 
through surveys using self-reported symptoms up to the time of assessment; this can be in the past 
weeks, the past three months (point or current prevalence) or six months or 12 months preceding 
assessment (period prevalence). Sometimes the estimate is for the individual lifetime prior to assessment 
time.81 Point prevalence is defined as the proportion of individuals who manifest a disorder at a given 
point in time. Period prevalence is defined as the proportion of individuals who manifest a disorder over 
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a specific period, while lifetime prevalence is the proportion of individuals in the population who have ever 
manifested a disorder and who are alive on a given day of the survey. Empirical evidence suggests that 
prevalence varies depending on the timeframe for which the prevalence is measured (point, period or 
lifetime), year of study, age, gender, location and the specific disorder.72,82 However, for lifetime 
prevalence of mental disorders, research has shown that estimates in a retrospective survey may be 
subject to recall bias in the measurement.83 
1.7.1  Prevalence of any mental disorders 
In 2001, the WHO published a seminal report entitled ’Mental health: new understanding, new hope’ that 
revealed a shocking number of about 450 million people who have experienced a mental disorder 
worldwide.9 More recently, the GBD 2017 estimated that about 970.8 million people worldwide have 
experienced a mental and substance use disorder.84 Other neurological disorders including Alzheimer’s 
disease in dementia (about 45 million people) and epilepsy (27.2 million people) were also reported 
worldwide.84 
Among hundreds of mental disorders listed in ICD or DSM, anxiety disorders, attention deficit hyperactive 
disorder (ADHD), autism spectrum disorder, bipolar disorder, conduct disorder, depressive disorders, 
eating disorders, idiopathic developmental (intellectual disability), schizophrenia and substance use 
disorder have been extensively studied or reported.9,84,85 
In children, the prevalence of mental disorders has been estimated to range between 10% and 20% 
worldwide.86 For example, a systematic review of global prevalence of mental disorders in children and 
adolescents reported a prevalence of 12% in 2005.79 A recent systematic review reported that the 
prevalence of any mental disorders in children was 13.4%.87 The most common mental disorders among 
children include anxiety disorders, depressive disorder, ADHD and disruptive disorders.86,87 Other 
disorders such as eating disorders and psychosis have also been documented.86  
Mental disorders with a high prevalence, other than neurological and substance use disorders, are 
assumed to be relevant to the Uganda population profile (as will be described in Section 1.10 below) 88 
and are the central focus of this thesis. Case definition or diagnostic criteria, preferably based on ICD-10 
or DSM-IV and the existing prevalence of the most common mental disorders, are described below. 
1.7.2 Anxiety disorders 
Anxiety disorders including PTSD are categorised in ICD-10 under F40-F48 (see Table 1.1).14 Research 
shows that the age-of-onset of anxiety disorders is usually early in life, with a median age of 11 years,89 
but may begin to occur at any age up to 75 years.90 Anxiety disorders are characterised by excessive 
fear that originates from psychological or autonomic causes/threats that causes distress, and impairment 
in social and other areas of functioning. Recurrent excessive distress, persistent worries about losing 
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major attachments, difficulties in concentrating, refusal to go out, reluctance to be alone, repeated 
nightmares, and repeated complaints of physical symptoms (headache, stomachache) are also 
common.14 According to ICD-10, these symptoms and diagnostic criteria vary by anxiety disorder 
subtype. For example, in separation anxiety disorder, fear, anxiety and avoidance need to be persistent 
for at least four weeks in children and six months or more in adults for diagnosis to be made. Anxiety 
disorders related place of occurrence (for example, crowds, public places, away from home) manifest as 
avoidance, apprehension, restlessness, fidgeting, tension headache, trembling, dry mouth and epigastric 
discomfort. 
Posttraumatic stress disorders (F43.1) usually arise from threat of injury or death from natural or man-
made causes,14 for example, exposure to war, serious accident, torture, witnessing death and rape. 
According to ICD-10, PTSD is characterised by the presence of three distinct but co-occurring clusters of 
symptoms: i) re-experiencing spontaneous often uncontrollable intrusions of the traumatic memory in the 
form of images or nightmares that are accompanied by intense physiological distress; ii) avoidance 
symptoms that involve restricting thoughts and distancing oneself from reminders of the event, as well as 
more generalised emotional and social withdrawal; iii) physiological manifestations, such as insomnia, 
irritability, impaired concentration, hypervigilance and increased startle responses. These symptoms must 
be severe enough to impair social, occupational or interpersonal function and co-occur for at least one 
month. 
1.7.2.1 Prevalence of anxiety disorders 
Research suggests that anxiety disorders are the most prevalent type of mental disorders in the 
population.59 Worldwide, the GBD 2017 estimated the prevalence of anxiety disorders at 3.8%, putting in 
perspective an absolute number of about 284 million people.84 A systematic review reported a pooled  
global current prevalence of anxiety disorders from 87 studies (published from 1980 to 2009) from 44 
countries of 7.3%.59 Among children, the prevalence of anxiety disorders is equally high. A systematic 
review reported a current global prevalence of anxiety disorders of 7.2% in children aged three to 17 
years.59 Another systematic review also reported a prevalence of 6.5% among children and adolescents 
globally.87 
It seems clear from previous studies that the prevalence of anxiety disorders is also influenced by the 
assessment period (current, period or lifetime). A systematic review of global lifetime prevalence of 
common mental disorders found that the lifetime prevalence of anxiety disorders (12.9%) was more than 
double the pooled 12-month prevalence estimate (6.7%).72 However it is worth noting that in this review, 
more studies (122 from 56 countries) investigated the period prevalence compared with the lifetime 
prevalence (70 studies from 39 countries).72 
15 
 
The GBD 2017 findings revealed a marked variation across countries, ranging from 2.07% in Vietnam 
and 8.54% in New Zealand.84 In addition, the finding of the GBD 2017 suggested that populations living 
in  high-income countries, according to the World Bank income classification of countries,27 experienced 
higher rates of anxiety disorders compared with LMICs.84 Similarly, previous systematic reviews found 
that low-income countries had the lowest rate (5.4%), followed by developed countries (7.6%), and that 
the highest rate was found in upper middle-income countries (emerging economy), at 8.6%.59 Further to 
economic status of a country, culture was found to play a role in the pattern of prevalence of anxiety 
disorders.59 A systematic review found that the global prevalence of anxiety disorders was higher (10.4%) 
in European and Anglo cultures (Western Europe, North America, Australasia) and lower (5.3%) among 
African cultures.59 In Africa, the lowest rate of anxiety disorders was recorded in West Africa with the 
highest prevalence in North Africa, led by Algeria, which had a prevalence of 5.07%,84 while the 
prevalence of anxiety disorders in Uganda was closer (3.53%) to the global average.84 
Evidence from existing literature revealed a variation in prevalence of anxiety disorders between women 
and men. The GBD 2017 report showed that anxiety disorders were more prevalent among women (4.7%) 
than men (2.8%).84 Another review reported that the pooled current prevalence of anxiety disorders was 
9.9% among women and 4.7% among men.59 A similar pattern was found in another systematic review, 
reporting a pooled period prevalence of anxiety of 8.7% among women and 4.3% among men.72 The 
lifetime prevalence of anxiety disorders follows a similar pattern, with women presenting with higher rates 
(18.2%) than men (10.1%).72 However, a study conducted after two decades of armed conflict in northern 
Uganda revealed a lower prevalence of anxiety disorders (26.6%), with rates higher in women (29.7%) 
than in men (23.1%).91 Regardless of geographical region, place of residence or time frame of anxiety 
disorders affect more women than men. 
Another factor observed in variations in the geographical distribution of the prevalence of anxiety 
disorders was place of residence. Research has found that within countries, the prevalence of anxiety 
disorders was much higher among people living in rural (16.9%) than urban (8.4%) settings.59 Similarly, 
the prevalence of anxiety disorders was found to be high among political conflict affected populations 
(9.0%) than non-conflict affected population (5.6%).59 The figures reported above are based on pooled 
prevalence of anxiety disorders across many countries. 
The findings of surveys conducted in Uganda, many of which have not been included in the systematic 
reviews discussed above, are fragmented, and varied between 18% and 67.4% by year of study, settings, 
and gender of included participants.92,93 For example, a survey conducted in political conflict affected 
districts of Northern Uganda using the Harvard Trauma Questionnaire reported the PTSD prevalence 
estimate at 54.3%, with higher rates in women (60.1%) than in men (45.6%).92 Another survey that 
examined PTSD amongst refugees and host communities in West Nile demonstrated that Sudanese 
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refugeed who experienced the highest number of traumatic events had the highest rates of PTSD (48%) 
than the host communities (18%).93 Another study conducted in 2005 among people formerly abducted 
by the Lord Resistance Army (LRA) reported 49% had PTSD and 59% had anxiety disorders.94 
1.7.3 Depressive disorders 
According to ICD-10, depressive disorders, consisting of major depressive disorders or episodic, are 
categorised among mood or affective disorders (Table 1.1; F30-F39).14 Depressive disorders occur in 
many forms (episodic [F32], recurrent [F33], or persistent [F34.1]) with varying degrees of symptom 
severity (mild, moderate or severe).14 Empirical evidence suggests that the median age-of-onset for 
disorders in this category is 30 years, although it varies, usually occurring up to 65 years, with a later age 
of onset associated with comorbidity.89,90 
Diagnostic criteria are based on an individual manifesting the primary symptom that includes changes in 
mood (e.g. feeling sad, empty, hopeless and irritable in children and adolescents or appearing tearful in 
adults), decrease in energy levels, decreased activity, and loss of interest and pleasure that cannot be 
explained by any other medical condition.14 Impaired thinking ability, reduced concentration and marked 
tiredness after activities that use minimal effort are common, including also disturbed sleep,  waking 
several hours early and lack of or reduced appetite. Other symptoms are changes in weight (significant 
weight loss of more than 5% in a month), loss of self-esteem and self-confidence, feelings of guilt or 
unworthiness, and suicidal ideation. These symptoms may be accompanied by somatic pain or 
symptoms.14 It is suggested that having five or more of the nine groups of symptoms in ICD-10 or DSM-
IV or DSM-5 consistently, for at least two weeks, causing distress and impairment in social and daily 
activities or important areas of functioning, are often regarded as severe depression.14,15 Although the 
above signs and symptoms are common, particularly in negative life events, it has been suggested that 
diagnosis should consider symptom duration and severity thresholds.14,15 
According to ICD-10, bipolar disorder is characterised by repeated episodes in which mood and activity 
levels are significantly disturbed. The disturbance consists of elevation of mood, increased energy and 
activity (mania or hypomania), or lowering of mood, energy and activities (depression). Recovery between 
episodes is often complete. Family history, premorbid personality, age of onset and long-term prognosis 
should be considered while making a diagnosis of this disorder.14 
1.7.3.1 Prevalence of depressive disorders 
Depressive disorders are common and associated with considerable impairment of functioning.95 It has 
been documented that some people may have only a single episode of depressive disorder but in others, 
it will be recurrent.14,15 According to the findings of GBD 2017, an estimated 3.4% (264 million) people in 
the world have experienced depressive disorders.84 The most common types of depression were: major 
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depressive disorder (MDD) accountings for 223.4 million people, bipolar disorder, 46 million people, and 
dysthymia, 33.3 million people.84 A previous systematic review found that the global point prevalence of 
MDD from 116 studies estimated current prevalence at 4.7%.82 Similarly, the review found higher rates 
of MDD in women (5.9%) than in men (3.8%). Similar patterns were observed in a 12-month prevalence 
of 3.7% with a nearly double prevalence rate 7.2% in women compared with 3.9% in men.82 
According to GBD 2017 findings, the prevalence of depression varies between countries, ranging from 
2% in Colombia to over 6% in Iceland.84 Of the 264 million people affected, about 19.2 million were from 
SSA, that includes Uganda.84 The findings showed that the prevalence of depression in Uganda (4.96%) 
is comparable with that seen in high-income countries (Australia, Finland, Sweden and the United States) 
and ranks amongst the top five countries in the world with the highest prevalence, after Iran, Algeria and 
Iceland.84 The point prevalence of depressive disorders also varies between world regions and countries, 
ranging from 6.6% combined prevalence for Africa and Middle East region,82 with prevalence varying 
between 0.05% in Japan and 73% in Afghanistan.82 The prevalence of bipolar disorders worldwide 
however is comparatively low, ranging from 0.35 to 1.2%, by country. 
The prevalence of depression in Uganda follows a consistent pattern reported globally and in other 
countries, with variations across settings and genders, although the results are largely inconsistent with 
higher prevalence rates of depressive disorders, compared to the combined global prevalence. A survey 
using BDI in two districts that differed in culture and social setting estimated that 17.4% of respondents 
had probable depression.96 This survey revealed a significant variation across the two districts: 26.3% in 
Northern Uganda which had experienced armed conflict and 6% in South-Eastern Uganda, a relatively 
peaceful district.96 Consistent with the international prevalence pattern reported by systematic reviews, 
depression was more prevalent among women (24.5%) compared to men (13.9%).96 
Another survey conducted in 2006 using HSCL-25 estimated that 67% of adult populations living in 
internally displaced person (IDP) camps in Northern Uganda had symptoms of depression.92 The same 
survey also found a higher rate of depression among women (78%) than in men (51.4%).92 A similar study 
conducted in 2005 in Northern Uganda reported that 70% of formerly abducted persons aged 17 years 
and older living in IDP and receptions centres had experienced depression symptoms.94 In contrast, a 
cluster community-based survey in 2013 in post-conflict northern Uganda using the MINI-Plus estimated 
24.7% of adult respondents had major depressive disorders.97 The authors reported that current major 
depressive disorders were higher in females (29.2%) than in males (17.0%).97 A cross-sectional survey 
in 2010 of HIV positive clients attending special clinics using the MINI Plus psychiatric interview estimated 
that 8.1% of the respondents had major depressive disorders,98 with higher rates in women (9.6%) than 
in men (4.1%). Furthermore, the findings of this survey suggest that the prevalence of MDD correlated 
with distance to health facilities. These authors reported that MDD prevalence was 7.8% in people who 
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lived more than five kilometres, 10.2% in people who lived between three and five kilometres, and only 
5.1% in people who resided within three kilometres of the health facility.98 
Similar to anxiety disorders, the prevalence of depressive disorders shows variations, by world region, 
country, prevalence period (current, period or lifetime), gender, year of study, depression subtype and 
survey instrument.82 
1.7.4 Eating disorders  
Eating disorders are categorised under behavioural syndromes associated with physiological disturbance 
and physical factors F50-F59 by ICD-10. Eating disorders involve abnormal eating behaviour that is not 
explained by a health condition and are not developmentally appropriate or culturally sanctioned.14,15 
Eating disorders include preoccupation with food as well as body weight, shape and image. Two 
commonly reported types in research literature are: i) Anorexia nervosa, common among younger women 
and adolescent girls. It is characterised by significantly low body weight for the individual’s height, age 
and developmental stage, induced and sustained at least 15% below the expected weight by the 
individual. A principle sign is a body mass index (BMI) of 17.5 kg/m2 or less, failure to gain expected 
weight that is not due to a health condition or unavailability of food. This is frequently accompanied by 
reduced energy intake (restricted eating), purging behaviours (such as self-induced vomiting, misuse of 
laxatives), and excessive exercise to prevent perceived weight gain. Low body weight or shape is central 
to the person's self-evaluation or is inaccurately perceived to be normal or even excessive.14,15 ii) Bulimia 
nervosa is characterised by persistent preoccupation with eating and craving for food, frequent, recurrent 
episodes of overeating, accompanied by repeated behaviours such as self-induced vomiting, misuse of 
laxatives, periods of starvation, and strenuous exercise to prevent weight gain. The individual is not 
significantly underweight and therefore does not meet the diagnostic requirements of anorexia nervosa. 
1.7.4.1 Prevalence of eating disorders 
According to the GBD 2017, the global prevalence of eating disorder was estimated at 0.2% (15.8 million) 
people in 2017. The most common was bulimia affecting around 12.5 million people, compared with 
anorexia, affecting 3.3 million people.84 The prevalence was much higher among women (0.29%) 
compared to men (0.13%).84 A review reported that the prevalence of eating disorders is generally very 
low in African settings.99 
1.7.5 Schizophrenia  
Schizophrenia is categorised in the ICD-10 block F20-F29: schizophrenia, schizotypal and delusional 
disorders. Research suggests that the median age for the onset of disorders in this category is rarely 
before the age of 14, but gradually occurs between the age of 15 and 17 years, with the interquartile 
range of 15-35 years for schizophrenia.90 
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Schizophrenia and other primary psychotic disorders are characterised by significant impairments in 
perception, thinking and alterations in behaviour.13,14 Schizophrenia manifests as persistent delusions or 
hallucinations, and disorganised thinking (typically manifesting as disorganised speech) and behaviours. 
The affected person experiences passivity and control, negative symptoms such as blunted or flat affect 
and volition, and psychomotor disturbances. The course of schizophrenic disorders can be continuous 
and episodic, with progressive or stable deficit and may have complete or incomplete symptoms and 
social recovery. To diagnose schizophrenia, at least one very clear or two or more symptoms that occurs 
are required. These symptoms must occur most of the time for at least one month.14,15 
1.7.5.1 Prevalence of schizophrenia 
According to the GBD 2017 analysis of prevalence of 354 diseases and injuries, the prevalence estimate 
of schizophrenia is 0.3% (about 19.8 million) people worldwide.84 This finding is consistent with the finding 
of a systematic review that pooled 132 studies from 46 countries.81 The authors estimated that the point 
prevalence of schizophrenia was 4.6 per 1,000 persons, the period prevalence was 3.3 per 1,000 persons 
and the lifetime prevalence was 4.0 per 1,000 persons.81 Another systematic review concluded that the 
prevalence of schizophrenia varied between four to seven per 1,000 persons.100 
The GBD 2017 also indicated that prevalence varies between countries, ranging from 0.15% in Central 
African Republic in the Africa region to 0.36% in Australia.84 The GBD 2017 findings however showed a 
distribution pattern of schizophrenia consistent with the previous systematic review, suggesting that this 
disorder is less common in lower income countries.100 
Compared with anxiety and depression disorders as mentioned earlier, the difference in prevalence that 
takes into account gender is less apparent (0.26% in men and 0.25% in women).84 This finding is 
consistent with the pattern reported by an earlier systematic review that revealed insignificant differences 
between genders, although with a slightly lower proportion of women than men affected.100 
1.8  Comorbidity 
Research suggests that a person with co-occurring diseases or disorders may experience more severe 
poor health compared to having a single disease or disorder.101 Comorbidities among mental disorder 
individuals is common. A national comorbidity survey conducted in the United States revealed that 79% 
of all people who had a mental disorder had three or more disorders.101 Previous research involving 
clinical samples found that 59% of patients diagnosed with anxiety as the principal DSM-IV diagnosis or 
a mood disorder had a lifetime history of comorbid depression, and 60% of patients with principal anxiety 
disorders had lifetime mood disorders.102 Similar results have been reported in other research.103,104 
Research suggests that substance use disorders are another common comorbid condition coexisting with 
mental disorders, for example, anxiety disorder with depressive disorder, documented particularly in 
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young adults.105 Mental disorders are also recognised to coexist with a range of other diseases, including 
diabetes, cancer, infectious diseases and cardiovascular diseases.106 The presence of co-occurring 
mental disorders and physical illness exacerbates the clinical and social consequences of the existing 
condition and makes it more challenging to manage the affected person.105 
1.9 Factors associated with mental disorders 
As noted previously, understanding the cause of mental disorders is challenging.53 Traditionally, the 
cause of mental disorders is believed to be mystical.107,108 Nowadays, mental disorders are known to be 
associated with multiple factors and include biological, psychological, socio-economic and environmental 
factors.109 Biological factors such as genetics, age and gender are the most common non-modifiable 
factors associated with mental disorders in literature.110,111 The focus of this thesis is on modifiable risk 
factors associated with the occurrence or triggers of mental disorders. 
1.9.1 Non-modifiable factors 
The  biological influence of mental disorders includes chemical and neurophysiological factors that have 
been linked to schizophrenia,112 while panic disorder, generalised anxiety disorder and obsessive 
compulsive disorder have been associated with family aggression.113 Another systematic review also 
found that MDD were common among first degree relatives.111 In contrast, a study of biological risk of 
developing PTSD among twins suggested life history and exposure to environmental factors influenced 
the onset of mental disorders.114 It can therefore be assumed that biological factors increase vulnerability 
to mental disorders, which may be triggered by social, economic and environmental factors that the 
individual is exposed to across their lifetime.42 
Age is one of the most important determinants of mental disorders. As previously mentioned (see Section 
1.7), research indicates that most cases of lifetime mental disorders have an earlier onset, with 50% 
starting to occur before the age of 15 years and up and 75% occurring by the age of 24 years,79,89,90,115 
although other disorders, such as dementia, usually start to occur after the age of 60 years.14 In addition, 
research suggests that occurrence of mental disorders in advancing age is linked to comorbidities.89 
Gender is another important factor in the prevalence of mental disorders. With the exception of substance 
use disorders,84 research has consistently reported that women experience a higher rate of disorders 
than men.82,84,91 However, a systematic review that examined the genetic association with MDD did not 
find important differences in inheritability between men and women.111 Therefore the focus of this thesis 
is on modifiable factors that trigger initial occurrence or relapse of mental disorders. 
1.9.2 Modifiable factors 
Understanding the underlying determinant of mental disorders can be used to target health service 
interventions such as preventative activities.109 Several epidemiological studies of mental disorders have 
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attempted to identify the determinants of mental disorders by examining their prevalence and 
correlations.80,110 Existing evidence published by WHO has clustered the determinants of mental 
disorders into individual, socio-economic and environmental factors.42 According to WHO, these 
determinants of mental health can be adverse or protective in nature.42 Furthermore, WHO indicates that 
the determinants or risk factors of mental disorders are not universal, but vary for an individual across 
their life course.42 
1.9.2.1 Individual factors 
These factors relate to inherent or learned abilities of a person to cope with their feelings and social 
environment as well as an individual’s physical health.42 The adverse factors include low self-esteem, 
cognitive or emotional immaturity, difficulties in communicating, medical illness or substance use.42 
However, according to the WHO, self-confidence or self-esteem, problem solving, the ability of an 
individual to manage stress or adversity, communication skills, being physically fit and healthy are said 
to be protective from development of mental disorders.42,116 The onset of mental disorders in adulthood 
has been associated with comorbid health conditions.89 In contrast, other studies have reported that living 
with chronic physical illness (such as HIV), CHD, cancer and diabetes is associated with the risk of 
developing depressive and anxiety disorders.28 
Risk of developing a mental disorder has been documented to occur across the different stages of life 
(pre-conception, prenatal, early childhood, school age, adolescent, early adult and old age).42 Research 
suggests that unwanted pregnancy or family conditions at childhood may increase the chances of harmful 
behaviours of mothers during pregnancy.117 Such harmful behaviours may include poor nutrition that 
cause nutrient deficiency, tobacco use, and alcohol and drugs use that potentially increase child 
vulnerability to mental disorders in later life.28 At infancy or early childhood, evidence suggests that 
separation of a child from the parent, particularly the mother, is said to affect their communication and 
social interaction at an early age and render their continuing life challenging.118 Negative life experiences 
at home or outside home, for example, experiencing bullying during childhood and later life, have been 
reported to affect cognitive and emotional skills.109 While at the adolescent stage of life risk to mental 
disorders is linked to physical ill-health, use of psychoactive substance (alcohol or drugs) influenced by 
peer or media and violence in the family or neighbourhood.42 In adulthood, the earlier trends in life may 
compound social, economic and environmental factors discussed later.109 
1.9.2.2 Social and economic factors 
Social and economic factors relate to the individual’s ability to thrive, influenced by their immediate social 
surroundings (family, community, friends and colleagues). Research has shown that living arrangements, 
such as overcrowding, a high number of people living in the household, poor housing quality,119 low 
income and assets,119-122 unemployment and under-employment,119,123 or occupation (work related 
22 
 
stress, e.g. army) increases risk of developing a mental disorder. Research also suggests that perceived 
or actual low social support, life changes (death of loved one, relationship challenges) are associated 
with higher rates of mental disorders in some individuals.124 Other factors include residency (rural or 
urban), forced displacement, marital status (broken family), culture and low educational or failure.119,123-
126 Experiencing loneliness,123 loss of a loved one,123 family conflict, exposure to abuse or violence, and 
unemployment have also been documented as being factors.42  
1.9.2.3 Education 
Restricted or lack of opportunity to gain education and income were advanced by WHO as being pertinent 
factors for economic viability.42 A low level of education has been associated with mental disorders 
(depression).119,123 Low levels of education have also been reported by a systematic review as a risk 
factor for dementia in both high-income countries and LMICs.127 
1.9.2.4 Societal and environmental factors 
According to WHO, sociocultural and geopolitical factors, including existence of mental disorders among 
household member(s), availability of basic services, cultural beliefs, attitudes and practices, have a 
bearing on the onset of mental disorders.42 These include poor access to basic services, discrimination, 
social gender inequalities, exposure to war or violence, which have been  associated with higher rates of 
depression and anxiety disorders.94,128 Other studies have reported that food insecurity (not having 
enough food) are also associated with higher rates of depression and PTSD.97,129 In addition, widowhood, 
being an orphan and abject poverty have also been documented as determinants of mental 
disorders.119,123,126 
Worldwide, a systematic review of the prevalence of severe mental disorders among prisoners found a 
higher incidence among this sub-population when compared with the general population.130 This finding 
was supported by another survey using full diagnostic interviews among persons detained in police 
facilities in Australia,131 which found that 33% of detainees had mood disorders (30% in men and 48% in 
women) and 15% had anxiety disorders (14% in men and 21% in women).131 Other disorders found 
across both genders include ADHD and behavioural disorders, substance use disorders, schizophrenia 
and other psychotic disorders, sleep disorders and learning disorders.131 The same study also indicated 
that 72% of respondents had a history of mental disorders.131 
A survey in Uganda involving young people affected (whether abducted or not) by LRA rebellion 
demonstrated that being in captivity was associated with higher risks of developing mental disorders.94 
Similar war related trauma was observed in Rwanda 1994 genocide survivors.132,133 Generally, people 
living in camps for IDP were found to have higher rates of war related mental disorders compared with 
those living in their own residence.94 Also people whose family members had been killed in the war or 
who experienced a higher number of traumatic events had greater odds of developing disorders.94 Other 
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research also reported that those people who were threatened with death or physically injured were more 
likely to be diagnosed with depression.134 Other forms of violence, including rape, and physical and verbal 
assaults, have also been associated with PTSD, anxiety and depressive disorders.135,136 Although the 
severity of trauma and individual characteristics play a major role in the development of PTSD,137 
research suggests that prior knowledge of, and preparedness for, torture, strong commitment to a cause, 
repeated exposure, and strong social supports have protective against the effects of PTSD.138 Since the 
risk factors for mental disorders discussed above may vary in individuals and across different settings, it 
is essential to understand how they may relate to the Ugandan context. 
1.10 Uganda 
Uganda, located in Eastern SSA, is bordered in the north by South Sudan, in the east by Kenya, in the 
south by Tanzania, in the south west by Rwanda and in the west by the Democratic Republic of Congo. 
The majority of people (about 80%) reside in rural areas, with scattered (isolated) patterns of settlement 
across 134 districts (as of June 2019).139,140 
According to the national population and housing census (2014) projection in 2018, Uganda has about 
40 million people.88,139 The population consists of 55% children (person below the age of 18 years), 8% 
orphans, 23% persons aged 18 to 29 years,88,139 and 4.1% persons aged 60 years or older.141 In addition, 
the population is made up of diverse cultures and entrenched religious beliefs, predominantly Christians 
and Muslims.88 
Uganda is a low-income country, according to the World Bank classification of countries.27 The majority 
of the Ugandan population relies on subsistence agriculture as the main source of livelihood or 
employment.88 For over two decades, some parts of Uganda were exposed to significant social and 
economic disruptions including complex emergencies such as the LRA armed conflict in the northern and 
north eastern regions between 1986 and 2007.142,143 The LRA conflict resulted in an unprecedented 
exodus of the population from their homes to IDPs and migration to urban centres. These people 
witnessed brutality, violence, death and damages to property and infrastructure, and most importantly, 
their way of life.142,143 Similar disruptions also occurred in the western region of Uganda caused by the 
Allied Democratic Front (ADF), affecting the greater districts of Bundibugyo, Kabarole and Kasese.144 
Other experiences include floods and droughts, followed by subsequently increased food insecurity and 
economic loss, particularly for the 80% of the population who depend on subsistence agriculture.88 
Concurrently, Uganda has continued to see emergence in chronic illness including cardiovascular 
diseases, high blood pressure, diabetes and cancer, besides major communicable diseases such as 
HIV/AIDS, malaria and tuberculosis.1,145  
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These factors are known to be associated with the occurrence of mental disorders as previously noted 
and as a result there is a need to estimate the Ugandan specific prevalence of mental disorders. Since 
the risk factors listed above may vary across different settings, the prevalence of mental disorders is likely 
to also vary. 
1.11 Need for further evidence specific to Uganda 
The burden of and prevalence data for mental disorders are frequently used by international bodies like 
WHO and national governments to guide planning of mental health services. Currently, the GBD study is 
the most influential source of evidence that provides a comprehensive estimate of the prevalence and 
burden of mental disorders for all countries, including Uganda.2,22,23 
As stated previously,  limited availability of epidemiological data for mental disorders from LMICs like 
Uganda in the GBD has been documented.29,30,146 Research shows that most (94%) of the published 
epidemiological studies of mental disorders comes from high-income countries, predominantly the United 
States, Western Europe, Australia and Canada.30 This finding is supported by other systematic reviews 
that have informed the GBD analysis of the burden of mental disorders.24 For example, a systematic 
review of the global prevalence of anxiety disorders included 87 studies from 44 countries in their analysis, 
only seven studies were from Africa and none were from Uganda.59 Similarly, a systematic review 
addressing the prevalence of major depressive disorders observed similar patterns in the availability of 
studies, with only one included study from Uganda.82 It is worth noting that for these two reviews, 59,82 
only three electronic databases, MEDLINE, PsycINFO and Embase, were searched for eligible studies 
published between 1980 and 2009. Furthermore, the observation of data sources used in the GBD burden 
of mental disorders 2013 shows that only two small studies from Uganda published in 2004 and 2005 
were included in the GBD 2010 study.24 Similarly, population specific disparities have been reported 
regarding the proportion of children included in the global prevalence of mental disorders.85 
Against the background of paucity of data and to enhance reporting, GBD methodology applies data 
modelling techniques to compute prevalence for countries without data.84 In this approach, the input data 
is obtained from a neighbouring country or countries from surrounding region(s) on the basis of similar 
socio-economic status.24,84 This is particularly critical, given the influence of culture and environmental 
factors contributing to mental disorders, as discussed in Section 1.9. above. The differences in risk factors 
that may exist between countries or regions necessitate country specific data. 
This epidemiological information is also adopted internationally to guide initiatives towards strengthening 
mental health services, including, for example, internationally the development of Mental Health Gap 
Action Programme 2008 (mhGAP),147 and the Mental Health Action Plan 2013-2020.148 At the country 
level, epidemiological data from GBD and mhGAP influence the inclusion of mental health among the 
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minimum health care package in the Ugandan national health sector plan.149 Data from the WHO mental 
health atlas 2017 indicates that mental health services remain underutilised and under resourced in many 
LMICs, in Uganda in particular.150 Therefore, local evidence such as the proportion of people with mental 
disorders could help inform and guide government in the allocation of resources and monitoring of the 
progress of implementation.80 In addition, lack of data from Uganda can severely restrict the utility of 
GBD. 
While a substantial number of epidemiological studies of mental disorders in Uganda appear to be 
available, the results are highly fragmented and the reported prevalence appears to vary 
considerably.91,94,96,97 This variability presents challenges in using it as a basis for evidence. As such, 
there is need to identify and synthesise all relevant data to generate prevalence estimates of mental 
disorders in Uganda. 
1.12 Methodological approach 
Prevalence refers to the proportion of a population with certain condition (in the context of this thesis, 
mental disorder) at a specific point in time.80 The accurate measurement of the prevalence of a disease 
or condition among a population is essential for key health decisions such as development of guideline, 
defining priority interventions and investment, delivery and the use of health services and also for 
monitoring changes in population health.80 Prevalence studies are typically observational study designs, 
most often cross-sectional surveys, that may involve taking a sample of participants from a specified 
restricted area (for example clinical population or a geographical area or specific gender or age groups) 
or may cover an entire country.80 A systematic review of these types of studies can provide reliable 
evidence to decision makers and is therefore preferred method for this thesis. 
1.12.1 Systematic review of prevalence studies 
A systematic review is a synthesis of primary research investigating a clearly formulated question(s), 
using systematic, explicit and reproducible methods.151 Historically, systematic reviews have been largely 
conducted to respond to questions about the effectiveness of health interventions including randomised 
control trails.152 Questions suited for this type of review are formulated with the population, intervention, 
comparator and outcome (PICO) mnemonic, which may not fit with other research designs.152 Over the 
years, systematic review methodology has evolved and adapted to fit in with the range of questions that 
may arise in the healthcare and study designs.153 For example, for a question addressing prevalence, it 
is crucial to described the geographical distribution of a condition of interest and the variation between 
subgroups using a cross-sectional study design. Prevalence reviews adhere to systematic review 
principles, however the review question is formulated with focus on the condition of interest, context and 
populations (CoCoPop) framework, to guide study eligibility.154  
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A systematic review of prevalence aims to systematically identify, critically appraise, collect and 
statistically meta-analyse data from all relevant observational studies (mainly cross-sectional studies) that 
match the predefined inclusion criteria.154 Existing evidence demonstrates a sharp increase in the number 
of published systematic reviews of prevalence globally between 2008-2018 inclusive.155,156 These 
encompass  systematic reviews of prevalence estimates for a range of diseases and conditions, including 
mental disorders.155  Unfortunately there remains a considerable inconsistency among the published 
systematic reviews of prevalence in the way they are conducted, risk of bias or methodological quality is 
assessed, and data synthesised and reported.155,156 Up-to-date, high quality systematic reviews of 
prevalence information can provide a better evidence needed to make crucial healthcare decisions.    
1.12.2 Methodological quality assessment of prevalence studies  
Several methodological issues of observational studies may bias the results of prevalence estimates.154 
For example, previous systematic reviews of prevalence of mental disorders demonstrate that non-
random sampling, small sample size and mode of administration (self-report questionnaire) were 
associated with higher reported rates of mental disorders from surveys.128 Similar methodological 
challenges as well as the type of prevalence estimate (point, period or lifetime) was reported by a 
systematic review addressing the global prevalence of anxiety disorders.59 These findings suggest that 
studies reporting prevalence estimates should provide sufficient information about the population and 
settings, measurement and analysis for readers to make independent judgement about the validity of the 
results.157   
Details pertinent to the population and settings requires accurate descriptions of the characteristics of the 
target population and the methods used to identify potential participants and to ensure each eligible 
participant has a known chance of selection.  Details regarding measurement of condition (mental 
disorder) are briefly discussed in Section 1.6 . Importantly, studies reporting prevalence data should be 
assessed if a standardised, reliable and valid, data collection instrument was used. Information 
addressing statistics or data analysis, should ensure that the statistical approach is appropriate to obtain 
estimates that are unbiased and associated with the correct statistical precision, exhibited by reporting 
response rate and confidence intervals for the estimates.157  A comprehensive list of items relating to 
each of these three major information domains have been summarised by a recent review. 157 
A recent systematic review identified 30 appraisal tools, only eight of which are specifically developed to 
assess methodological quality of prevalence studies.157  However, this review finding shows lack of 
consensus about the domains to assess in prevalence studies, introducing variability among the 




1.12.3 Synthesis of prevalence data 
Another important element of a systematic review of prevalence studies is the approach adopted for 
synthesis, either as a qualitative narrative synthesis or statistical meta-analysis where possible.156,158  
Different statistical meta-analytic approaches are available.156 Methods used to transform prevalence 
estimates also vary, including arcsine square root, Freeman-Tukey Double Arcsine Transformation, and 
logit transformation among others.156  
1.12.4 Reporting of a systematic review of prevalence studies 
A systematic review of prevalence studies should be reported fully and transparently to allow readers to 
evaluate the strengths and weakness of the overall results and the conclusions.158,159 The recent review 
that evaluated how systematic reviews of prevalence are conducted found three commonly used guides 
for the reporting.156 These are Preferred Reporting Items for Systematic Review and Meta-analysis 
(PRISMA),159 Meta-analysis Of Observation Studies in Epidemiology (MOOSE)160 and Guidelines for 
Accurate and Transparent Health Estimates Reporting (GATHER)161.156 The majority (68.5%) of the 
published systematic reviews of prevalence studies employed the PRISMA reporting guideline.156  
Detail of the approach for the conduct of the systematic review of prevalence estimates in this thesis is 
presented in Chapter 2, highlighting the a priori decisions regarding location and identification of studies, 
determination of their eligibility, quality assessment and data collection and statistical analysis. 
1.13 Summary and significance of this study 
In this chapter, literature regarding mental disorders has been examined. It is now recognised that mental 
disorders occur in all countries worldwide, some of which are highly prevalent and debilitating.1,9,19,24,25,162 
Because mental disorders lead to significant health, social and economic consequences to individuals, 
family and society (Sections 1.3 and 1.4), ascertaining their prevalence is important. The prevalence of 
mental disorders, like any other disease or health conditions, represents a common starting point for 
health services improvement planning, resource allocation and policy development.80 Evidence informed 
policy and planning may be achieved through the adoption of synthesised results as input. This 
acknowledgement has led to a growing interest in improving access to health care for people with mental 
disorders worldwide, particularly those in LMICs.147,148 Prevalence is an important input for measuring 
disease burden,22-25,95 planning and monitoring effectiveness of interventions to reduce the incidence and 
impact of mental disorders.80,109 However, research invariably shows that evidence on mental disorders, 
particularly in LMICs, is conspicuously lacking,29,30,82,85,146 The lack of nationally available prevalence data 
for Uganda may hamper the planning and implementation of interventions related to mental disorders. 
Therefore, Uganda specific studies are needed to inform future decisions for the provision of health 
services. This research may assist with the provision of evidence to support mental health services 
28 
 
planning, policy adoption and implementation to improve access to health care for people with mental 
disorders in Uganda. 
1.14 Objective and review questions 
The objective of this thesis was to determine prevalence estimates of mental disorders in Uganda. 
Specific questions addressed by this thesis were: 
1.1. What is the prevalence of mental disorders among children in Uganda? 
1.2. What is the prevalence of mental disorders among adults in Uganda? 
1.3. What are the common mental disorders among children and adults in Uganda? 
1.15 Organisation of this thesis 
The remainder of this thesis comprises three chapters. Chapter 2 presents the published systematic 
review protocol prepared according to the JBI methodology for conducting a systematic review of 
prevalence studies.163 Chapter 3 presents the final systematic review of prevalence of mental disorders 
in Uganda submitted for publication, and Chapter 4 further discusses the findings of the review in the 
context of existing literature and in light of information presented in this introductory chapter. Chapter 4 
also presents the implications for policy, practice and future research as well as concluding remarks. 
Due to the nature of this thesis, by publication and abiding to the guidelines of the systematic review 
methodology, the need for repetition of some information, for example, introduction and methods sections 
in Chapters 1, 2 and 3, is unavoidable. In addition, the framing material (Chapters 1 and 4) for this thesis 
is written in Australian English, Chapters 2 and 3 are presented in their respective and required publication 
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Mental disorders account for a substantial proportion of health burden.  They contributed to approximately 
10% of global burden of disease as measured by disability-adjusted life years (DALYs) in 2010.1 The 
DALY is a quantitative health measure that combined the non-fatal component of the disease or injury as 
years live with disability (YLDs) and the fatal component as years of life lost (YLLs) or premature death.2 
The Global Burden of Disease (GBD) studies 2016 reported mental disorders as the leading cause of 
YLDs in 2016 affecting an estimated 1.1 billion people globally.3 Despite the existence of a wide range of 
mental, neurological and substance use disorders,4,5 depression and anxiety disorders are among the 
top ten causes of ill health in nearly all countries globally.1,3 Importantly, the World Health Organization 
(WHO) 2017 report on the burden of mental disorders indicates that globally, 80% of people with mental 
disorders are living in countries classified by the World Bank6 as low- and middle-income countries (LMIC) 
like Uganda.7 
Diagnosis of mental disorders is consistently increasing. Previous studies have shown that the number 
of cases of mental disorders increased by 41% globally between 1990 and 2010.1 Conversely, other 
authors have forecast that the prevalence of mental disorders in Sub-Saharan Africa (SSA) is likely to 
increase by 130% by 2050 due to epidemiological and demographic transitions.8 Uganda is part of SSA. 
Demographic factors, particularly age, appear to have a strong association with the burden attributable 
to mental disorders in a population. Empirical evidence suggests that a substantial proportion of all lifetime 
cases of mental disorders begins to occur early in life (nearly half by the age of 14 and three-quarters by 
the age of 24).9 These age groups constitute an estimated 80% (50.3% are under 15 years and 30.6% 
are 15 to 24 years) of the Ugandan population.10 The age distribution and the age of onset of mental 
disorders can explain the empirical evidence that indicates that the higher burden of these conditions 
among people aged 15 to 49 years.1,11,12 The demographic attribute of mental disorders suggests that 
Uganda, with about 95% of the population below 60 years, is likely to be disproportionately affected,13 
highlighting the need to evaluate the prevalence of mental disorders across all age groups. 
The cause of mental disorders was once believed to be mystical.14,15 Nowadays, research indicates that 
there is a relationship between biological (infection, brain damage and genetics), psychological (fear, 
failure and anger) and social (education, social class, self-esteem, loss of a relationship and societal 
expectation) factors that triggers mental disorders.4,7,16,17 In addition, mental disorders are associated 
with chronic physical illnesses such as human immunodeficiency virus (HIV), coronary heart disease, 
cancer and diabetes.18 In developed countries, research shows that people with mental disorders die 15 
to 20 years earlier due to chronic physical illness.19 These factors present challenges and opportunities 
for policy-makers and health service planners to improve the mental health of about 40 million people in 
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Uganda. Despite the existence of factors that trigger mental disorders, the prevalence of mental disorders 
in Uganda remains poorly understood.1,20 
The successful planning and implementation of interventions to improve health services for people with 
mental disorders in any country like Uganda require reliable prevalence data on the mental disorders that 
are confronting its populations.21,22 Accordingly, in response to the global burden of mental disorders,23 
the WHO developed the Mental Health Gap Action Programme (mhGAP) in 200824 and the mental health 
action plan 2013-202025 in 2013 to guide efforts to improve access to health services for people with 
mental disorders. Improving access to health services is dependent on interactions between multiple 
factors within health service delivery systems.22,26,27 These factors include demographic profiles (age, sex 
and others), social structures and health beliefs of individuals as well as resources available to the 
individual or family, health information and services. Lastly, the individual or population health needs 
(perceived or evaluated health status) will also influence access to health services.22,27 For example, 
studies of behavior of people with mental disorders or their family suggest that their willingness to seek 
help or utilize health services is driven by their self-perceived health status.28-30 This highlights the 
importance of prevalence data on mental disorders for each country as one of the stimuli to increase 
awareness and redirect efforts to improve access to health services by people with mental disorders. 
A preliminary search for previous systematic reviews on the prevalence of mental disorders in Uganda 
was conducted in PROSPERO and PubMed. The search found no specific previous systematic reviews 
on the prevalence of mental disorders in Uganda. 
2.2 Review questions 
The questions to be addressed by this systematic review are: 
i. What is the prevalence of mental disorders in children under 18 years in Uganda? 
ii. What is the prevalence of mental disorders in adults 18 years and over in Uganda? 
iii. What are the common mental disorders among children and adults in Uganda? 
2.3 Inclusion criteria 
2.3.1 Participants 
This review will consider studies that include children below 18 years and/or adults 18 years and over 
with or without co-existing physical health problems and without restriction on gender. The participants 
are representative of the general population (representativeness will be determined by participant 




This review will include studies that investigate the prevalence of mental disorders defined according to 
diagnostic criteria in the Tenth Revision of the International Statistical Classification of Diseases and 
Related Health Problems (ICD-10) or the Diagnostic and Statistical Manual of Mental Disorders (DSM)-
IV or DSM-5.4,5 Included studies must use validated diagnostic instruments. Eligible studies must 
identify/report on one or more specific mental disorders such as depressive disorders, anxiety disorders, 
bipolar disorder, and schizophrenia, and conduct disorder. Eligible studies will report current (one week 
or one month), period (six month or 12 months) or lifetime estimates of the prevalence of mental disorders. 
The review will exclude studies that focus on the prevalence of substance use and neurological disorders 
such as alcohol use disorders, drugs use disorders, dementia, migraine, epilepsy and others. 
Furthermore, studies will be excluded if diagnosis of mental disorders reported is not based on validated 
instruments. 
2.3.3 Context 
This review will include studies that report on prevalence of mental disorders conducted in the community, 
schools, general hospitals/health facilities/primary healthcare located in Uganda. It will exclude studies in 
which participants are drawn from prisons or mental health clinics whereby prevalence of mental disorders 
is not representative of the general population. 
2.3.4 Types of studies 
This review will consider observational study designs: population based cross sectional studies and 
cohort studies. Other study designs that provide indications of prevalence of mental disorders including 
randomized control trails will be considered for inclusion. 
Studies published after the development of the mhGAP-Intervention Guide 2010 will be included to 
capture recent trends in the prevalence of mental disorders in Uganda. No restriction to language of 
publication or sample size will be set. 
2.4 Methods 
This review will follow the Joanna Briggs Institute (JBI) guidelines for conducting and reporting a review 
of prevalence and incidence, and preferred reporting items for systematic reviews and meta-analyses 
(PRISMA).21,31,32 
2.4.1 Search strategy 
A three-step search strategy will be used to locate both published and unpublished studies of the 
prevalence of mental disorders in Uganda.33 An initial limited search of PubMed and PsycINFO has been 
undertaken followed by analysis of the text words contained in the title and abstract, and of the index 
terms used to describe the article.34 This informed the development of a search strategy tailored for each 
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information source. Search strings were generated in consultation with a research librarian. A full search 
strategy for the PubMed electronic database is detailed in Appendix 2-I. Searching for additional studies 
from gray literature (not commercially owned or published) from government departments, International 
agencies and academics institution repository or websites will be conducted using similar keywords from 
the search strings. Hand searching in grey literature including technical evaluation reports and websites 
(from Uganda government departments/Ministry of Health and WHO-iris and AfroLib).35 The reference 
list of all eligible studies will be screened for additional studies. 
2.4.2 Information sources 
The databases to be searched include: PubMed, Scopus, Google Scholar, PsycInfo, Embase, African 
Index Medicus (African Journal of Psychiatry, African Health Observatory), Web of Science, program 
survey reports, conference papers, African local journals, dissertations, bulletins and factsheets. 
The trial registers to be searched include: Cochrane Central Register of Controlled Trials 
The search for unpublished studies will include: survey reports and program evaluation reports. The 
following are websites that will be searched in addition to the Uganda Ministry of Health/government 
websites: worldwidescience.org https://worldwidescience.org/, WHO Institutional Repository for 
Information Sharing (WHO-IRIS): http://apps.who.int/iris,  AfroLib http://afrolib.afro.who.int, World Bank 
group: https://openknowledge.worldbank.org/discover?rpp, 
2.4.3 Study selection 
Following the search, all identified citations will be uploaded into Endnote V8 (Clarivate Analytics, PA, 
USA) and duplicate citations removed. Two independent reviewers will initially pilot and then screen titles 
and abstracts against the inclusion criteria. Studies that meet or may potentially meet the inclusion criteria 
will be retrieved in full, and their details imported into JBI System for Unified Management, Assessment 
and Review Information (JBI SUMARI) software. The full text of selected studies or reports will be 
retrieved and assessed in detail against the inclusion criteria using JBI-SUMARI. Full text studies that do 
not meet the inclusion criteria will be excluded and reasons for exclusion will be provided in an appendix 
in the final systematic review report. Included studies will undergo critical appraisal. The result of the 
search will be reported in full in the final report and presented in a PRISMA flow diagram. Any 
disagreements that arise between the reviewers will be resolved through discussion, or with a third 
reviewer (EA) to determine the final inclusion. 
2.4.4 Assessment of methodological quality 
Eligible studies will be critically appraised for methodological quality by two independent reviewers using 
the standardized critical appraisal instrument for prevalence studies in JBI SUMARI.36 Prior to embarking 
on a full review of all selected papers, an initial piloting of the critical appraisal tool in a subset of the 
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selected papers will be performed by two independent reviewers. Any disagreements or uncertainties that 
arise during methodological quality assessment will be resolved through discussion or with a third 
reviewer (EA). The results of critical appraisal will be reported in narrative and tabular formats. All studies 
that meet the inclusion criteria, regardless of the results of their methodological quality, will undergo data 
extraction and synthesis (where possible). 
2.4.5 Data extraction 
Data will be extracted using the standardized data extraction tool for prevalence and incidence.37 
Appendix 2-II presents a modified version of the data extraction tool for this review. Prior to extraction, 
two reviewers will independently pilot the data extraction tool customized in JBI SUMARI with a subset of 
the selected studies and meet to review the consistency. After piloting, JO will extract the data. The data 
extracted will include specific details about the participants, condition and other characteristics including:  
i) general information: author(s) name, study title and aim, year of study and country of study, publication 
type or source of data (journal or report), socioeconomic data, especially income level, where available; 
ii) study characteristics: study design, characteristic of the study population (age and gender), sample 
size, diagnostic instrument used and sampling methods (in studies investigating mental disorders of 
children, this will include characteristics of the person providing the information. e.g. parent or caregiver 
or teacher or child); 
iii) outcome information: proportion of people reported with either current or period or lifetime prevalence 
of mental disorders, or outcome data to allow an estimation of the effect size such as statistical test and 
author’s conclusion (in cohort study designs that measure prevalence of mental disorders and where data 
is taken multiple times, only data from the last point will be extracted). 
Any disagreements that arise between the reviewers at piloting or where the reviewer is uncertain on 
particular study details to extract, will be resolved through discussion or with the other reviewers (EA). If 
required, the author(s) of the paper (s) will be contacted to request for missing or additional data. 
2.4.6 Data synthesis 
Prevalence data extracted from the included studies will, where possible (e.g. studies using uniform case 
definitions, the same measures of outcome, context and approaches), be pooled in a statistical meta-
analysis using Metafor (Free Software Foundation, Inc., Boston, USA).38 Prevalence data from the 
included studies will be transformed using a Logit transformation to calculate the weighted summary of 
proportion under a random effect model. The effect size will be expressed as a proportion with 95% 
confidence intervals around the summary estimate. 
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Heterogeneity will be assessed using the Chi-squared, Tau-squared and I-squared tests.39,40 To explore 
potential sources of heterogeneity from the included studies, characteristics likely to modify prevalence 
estimates will be considered for subgroup analyses. The following subgroups will be analyzed, where 
possible: age (under 18 years and 18 years and over), diagnostic instruments used, specific diagnosis 
(e.g. depression, anxiety, etc.), socio-economic status and study design. Sensitivity analyses will be 
performed to explore the impact of individual studies on the overall calculated prevalence estimates. This 
will be performed by investigating whether dropping or adding primary studies with (say) slightly non-
standard disease definitions will make a difference. 
Where statistical pooling in a meta-analysis is not possible due to heterogeneity, the findings will be 
presented in narrative form including tables and figures to aid in data presentation. Sources of 
heterogeneity and reason for which it is determined to be inappropriate to pool data will be specified in 
the systematic review report. 
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Appendix 2-I: Search terms and strategy 
Search terms in PubMed 
1. “Mental disorders”[MeSH Terms] 
2. Mental disorders[textword] 
3. “Mentally ill persons”[MeSH Terms] 
4. Mentally ill person*[textword] 
5. “Psychopathology”[MeSH Terms] 
6. Psychopathology[textword] 
7. “Psychiatric”[MeSH Terms] 
8. Psychiatric[textword] 
9. “Child psychiatry”[MeSH terms] 
10. “child psychology” [MeSH terms] 
11. "diagnostic and statistical manual of mental disorders"[MeSH Terms] 
12. “Prevalence”[MeSH Terms] 
13. Prevalence[textword] 
14. Epidemiology[textword] 
15. “Uganda”[MeSH Terms] 
16. Uganda[textword] 
Search strategy in PubMed 
17. Search 1: #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 
18. Search 2: #12 OR #13 OR #14 
19. Search 3: #15 OR #16 
20. Search 4: #17 AND #18 AND #19 
21. Search limited to: #20 AND Limit 2010 to 2017  
41 
 
Appendix 2-II: Data extraction (Munn et al.,37) 
Study details 
1. Reviewers 1……………………………………….2………………….…………… 
2. Study ID ……………………………………………………………………………… 
3. Date…………………………………………………………………………………… 
4. Study title…………………………………………………………………………….. 
5. Authors…………………………………………………………..……………...….... 
6. Country of study…………………………………………………………………...…. 
7. Year of study …………………………. publication 
year/date…………………………...………………. 
8. Journal/source name………………………………………………………………… 
9. Aims of the study…………………………………………….................................. 
Study methods 
10. Setting…………………………………………………………………..................... 
11. Study design……………………………………………………………………....... 
12. Characteristic of the study population (age and gender): M……f..….age…..… 
13. Socio-economic status (if data available) …………...………………………..… 
14. Study sample size…………………. sampling methods used……………........ 
15. Mental disorders diagnostic instrument used………………………………….. 
16. Person providing the information (Respondent in case of a child: parent or caregiver or teacher 
or child), age group and gender if specified 
17. Methods of data analysis………………………………………………………… 
18. Ethical approval……………………………………………………………………… 
Results 
19. Diagnosis (mental disorders) ……………………………………………………… 
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Mental disorders account for a substantial proportion of health burden globally, but little is known about 
its true prevalence in Uganda. This systematic review was conducted to determine the prevalence of 
mental disorders among children and adults in Uganda. 
Methods  
A comprehensive systematic search was conducted in PubMed, Embase, PsycINFO, Scopus, Web of 
Science databases and grey literature sources for studies reporting prevalence of mental disorders in 
Uganda from January 2010 to April 2018 inclusive. The included studies had to assess mental disorders 
using internationally accepted diagnostic criteria and validated instruments. Identified studies were 
critically appraised by two independent reviewers and prevalence pooled using the random-effects model.  
Certainty in the pooled prevalence estimates was evaluated using the Grading of Recommendation, 
Assessment, Development and Evaluation approach.  
Results  
Twenty-four studies were included in the review. The prevalence of any mental disorder was 22.9% (95% 
C.I 11.0%-34.9%) among children and 24.2% (95% C.I 19.8%-28.6%) among adults. Prevalence of 
anxiety disorders was 14.4% (95% C.I 4.9%-24.0%) and 20.2% (95% C.I 14.5%-25.9%) among children 
and adults, respectively. Prevalence of current depressive disorders in children was 22.2% (95% C.I 
9.2%-35.2%) and 21.2% (95% C.I 16.8%-25.6%) in adults. 
 Limitations 
Substantial heterogeneity (I-square statistic >90%) was observed across analyses that was not explained 
by subgroup analysis. The included studies were limited to various geographic regions of Uganda with 
none conducted countrywide.  
Conclusions  
Anxiety disorders and depression affect one in four Ugandans. Health services decision-makers should 
consider such prevalence in planning. Further population-based studies are required to address the lack 
of information regarding other mental disorders. 
Key words 




Mental disorders encompass health conditions commonly characterised by unexpected disturbance in a 
person’s cognition, emotion and behavioural control, preventing them from functioning effectively [1, 2]. 
Severe mental disorders have also been shown to reduce life expectancy by approximately 20 years [3-
5]. According to the Global Burden of Disease Study (GBD) 2016, an estimated 1.1 billion people globally 
were affected by mental disorders [6], with depression and anxiety disorders ranked among the top ten 
causes of years lived with disability (YLDs) in nearly all countries [6, 7]. Empirical evidence also suggests 
that 10-20% of children and adolescents globally experience mental disorders [8, 9]. Strikingly, the World 
Health Organization (WHO) World Health Report 2017 indicated that 80% of people with mental disorders 
are from low- and middle-income countries (LMICs) [10]. As a cause for greater concern, the prevalence 
of mental disorders in Sub-Saharan Africa (SSA), including Uganda, is predicted to increase by 130% 
from 2010 to 2050 [11]. Despite this, reliable epidemiological studies of mental disorders in LMICs, 
including Uganda, appear sparse [12-15]. 
Research indicates that there is a relationship between biological (age, infection, nutrition and genetics), 
psychological (fear, failure and anger) and social (education, family function and structures, 
neighbourhood, social class, self-esteem, loss of a relationship and societal expectations) factors that 
trigger mental disorders [16, 17]. People living in LMICs exhibit and are exposed to many of these factors 
known to fuel mental disorders. For example, previous studies show that people with HIV, coronary heart 
disease, cancer and diabetes are more likely to develop anxiety disorders and depression [18, 19]. 
Similarly, populations in conflict zones including South Asia, the Middle East, the Balkans and Sub-
Saharan Africa exhibit increased prevalence of mental disorders [20-22]. In addition,  up to 75% of cases 
of mental disorders in adulthood start before the age of 24 years [23, 24], with people 10-29 years old 
experiencing the greatest burden [7, 15, 25]. 
These scenarios are all relevant to the Ugandan context. Uganda has a population of approximately 39 
million people (June 2018) living across 122 districts [26, 27]. Approximately 55% of the population are 
children under 18 years of age and 23% are 18-29 years old who predominantly live in rural areas and 
are subsistence farmers [27, 28].  Eight percent are orphans [26, 28]; there is high prevalence of human 
immunodeficiency virus (HIV) and malaria, as well as a rising burden of non-communicable chronic 
diseases, including cardiovascular disease, cancer, and diabetes [25, 29]. These are all factors that may 
influence the prevalence of mental disorders in Uganda. In addition, the country has a recent history of 
over two decades (1986-2007) of armed conflicts in the northern and north-eastern regions [30, 31]; 
exposure to war may influence social, economic and health and the prevalence of mental disorders. 
Although studies have reported prevalence of mental disorders in different populations, there has been 
no attempt to consolidate prevalence studies derived from Uganda.  
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Reliable prevalence data regarding mental disorders is required to inform prioritisation and investment in 
strategies to improve access to and delivery of health services in Uganda [32, 33]. At an international 
level, the enormous burden of mental disorders has guided the development of the WHO Mental Health 
Gap Action Programme (mhGAP) [34] and the WHO Mental Health Action Plan 2013-2020 [35]. To 
translate these plans into action, each country is required to customise the plan to their health service 
context. The objective of this systematic review was to determine the recent prevalence of mental 
disorders in children and adults in Uganda, so as to better inform future planning and delivery of health 
services for people with mental disorders. To date, no systematic review has been conducted 
investigating the prevalence of mental disorders in children and adults in Uganda. 
3.2 Methods 
This systematic review adhered to the Joanna Briggs Institute (JBI) methodology for conducting and 
reporting systematic reviews of prevalence and the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) guidelines [32, 36, 37]. The protocol was registered with the International 
Prospective Register of Systematic Reviews (PROSPERO, registration number CRD42018101986) and 
published a priori [38]. 
3.2.1 Inclusion and exclusion criteria 
Studies were considered eligible if they: i) examined the prevalence of mental disorders in participants of 
any age (children <18 years and adults ≥18 years); ii) used diagnostic criteria for mental disorders from 
the 10th revision of the International Classification of Diseases and Related Health Problems (ICD-10) or 
the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV or DSM-5) [1, 2]; iii) used a validated 
instrument to assess a mental disorder (studies of neurological and substance use disorders were 
excluded); iv) studies were conducted in Uganda and participants were sampled from the community or 
institutions including hospital or clinic settings (studies conducted in psychiatric hospitals/clinics or prisons 
were excluded); v) studies were observational study designs (cross-sectional, cohort and case-control 
studies) conducted and published in 2010 or later (until 30 April 2018). Inclusion was limited to studies 
conducted post-2010 to provide a clearer picture of current estimates in Uganda [38]. If studies were 
published after 2010 and the date of study was not provided, these studies were included. 
3.2.2 Literature search 
A three-step approach [38] to comprehensively search for studies was conducted between 1st and 6th 
May 2018. The following citation databases were searched: PubMed, Embase, PsycINFO, Scopus and 
Web of Science. Google Scholar, ProQuest (Dissertations and Theses), and websites, the Republic of 
Uganda Ministry of Health Knowledge Management Portal and the WHO Institutional Repository for 
Information Sharing (WHO IRIS), were also searched. The combination of search terms used was 
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developed in PubMed and adapted for each database searched using database-specific indexing terms 
for ‘mental disorders’, ‘prevalence’ and ‘Uganda’. The full search strategy for each information source is 
available in Appendix 3.I. The search was supplemented by hand searches of reference lists of included 
studies. To correspond with the review eligibility criteria (see above), searching of all sources was 
restricted to studies published from January 2010. 
3.2.3 Selection of studies  
All records retrieved from the search were uploaded into Endnote X8 (Clarivate Analytics, PA, USA) and 
duplicates removed. One reviewer (JO) screened titles and abstracts to determine study eligibility. 
Citation details of potentially relevant studies were imported into the JBI System for Unified Management, 
Assessment and Review Information (JBI SUMARI) software [39]. The full texts of these studies were 
retrieved and assessed in detail by a single reviewer (JO) against the inclusion criteria. Reasons for 
exclusion of retrieved studies were recorded. Where necessary, decisions regarding inclusion and 
exclusion of studies were confirmed via discussion with the second reviewer (EA). 
3.2.4 Methodological quality assessment 
Methodological quality of the included studies was assessed independently by two reviewers (JO and 
SM) using the JBI standardized critical appraisal instrument for prevalence studies [40]. The instrument 
has nine items to assess for risk of bias in sampling, analysis and measurement in primary studies. The 
total score ranges from 0 to 9 for individual studies. Only criteria with a ‘yes’ score was considered to 
have no risk of bias in that criteria and was given one point. Disagreement was resolved by consensus 
or with a third reviewer (EA). 
3.2.5 Data extraction 
For each included study, descriptive details, including participant characteristics, setting/district and 
methodological details were extracted, as well as prevalence data using the JBI data extraction form for 
prevalence studies [32]. Full data extraction was initially piloted with six studies. Prevalence data from 
each study was extracted independently and in duplicate by two reviewers (JO and EA). Discrepancies 
in prevalence data extracted from one study [41] were resolved via discussion (JO and EA). In addition, 
two studies (three articles) were included where the overlap with the reported age strata (14-19) [42, 43] 
and 15-24 [44] violated the cut-off point (<18 years for children or ≥18 years for adults) predetermined for 
this review [38]. Corresponding authors of ten studies [45-54] were contacted for additional information. 





3.2.6 Data analysis 
Pooled prevalence estimates of any mental disorder, anxiety and depression in children and adults were 
calculated using DerSimonian and Laird random effects meta-analysis [55] set to a logit transformation 
model [56] in OpenMeta-Analyst software [57]. Analyses were undertaken by year of publication to 
observe period patterns in the data, where possible. I-squared (I 2) statistic and Chi-squared (χ2) test 
(Cochran’s Q) were used to assess heterogeneity across studies [58, 59]. Potential sources of 
heterogeneity were investigated, where possible, with subgroup analyses based on type of instruments 
used (in at least three or more studies) to assess mental disorders, location from which participants were 
sampled (health facility or community) and sample size (<300, 300-500 and ≥501). 
To avoid multiple counting of respondents in circumstances where: i) a single study reported more than 
one mental disorder [50, 60-63]; or ii) two or more articles published results from the same study and data 
collection period [42, 43, 60, 61]; only results reporting the highest number of cases were used in the 
analysis of the overall pooled prevalence of mental disorders but were pooled for specific disorder 
estimates. This analysis of the highest number of cases was not specified in advance [38]. The certainty 
of the pooled prevalence estimates was determined using the Grading of Recommendation, Assessment, 
Development and Evaluation (GRADE) approach for systematic reviews of prognosis [64]. 
3.3 Results 
3.3.1 Identification of studies 
The literature search identified 632 records, from which 24 studies (26 articles) with 17,893 participants 
were included. Figure 3.1 illustrates the process of study selection and inclusion. Of the 632 records, 202 
were excluded as they were duplicate records and 339 were excluded after screening titles and abstracts 
for their relevance.  A total of 91 records were potentially eligible for full-text retrieval for detailed 
assessment. Of these, 65 (two conference abstracts [48, 51] and 63 full text articles) were excluded and 
the reasons for exclusion are presented in Figure 3.1. The remaining 26 publications from 24 studies 




Figure 3.1 Flow diagram of the process of study identification and inclusion 
3.3.2 Characteristics of included studies 
The key characteristics of the included studies are presented in Table 3.1. Five studies (six publications) 
were conducted on 3803 children [42, 43, 50, 62, 63, 69] and 19 studies on 14,091 adults [41, 44, 45, 50, 
54, 60-62, 65-68, 70, 72-75, 77-79]; two of the latter [50, 62] also assessed prevalence in children.  Two 
of the included studies were conducted in 2010, three in 2011, three in 2012, three in 2013 and four in 
2014. Seven studies did not report year of data collection. 
In children, five studies reported prevalence of anxiety disorders (including post-traumatic stress disorder 
[PTSD], generalized anxiety disorder [GAD], specific phobias and separation anxiety disorder) [42, 50, 
62, 63, 69], while four studies reported prevalence of depressive disorders (major depressive disorder 
[MDD] and dysthymia) (Table 3.1) [43, 50, 62, 63]. One study reported the prevalence of psychotic 
disorder syndromes and eating disorders among children [42, 43]. In adults, five studies provided 
prevalence data on anxiety disorders (PTSD and GAD) [50, 54, 61, 62, 67] and 19 studies provided 
prevalence data on depressive disorders (MDD and bipolar disorder) [41, 44, 45, 50, 60, 62, 65, 66, 68, 
70, 72-79].  All 24 included studies reported point prevalence, although two of the studies also reported 
lifetime prevalence [76, 77] of mental disorders. 
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Seventeen studies used Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) 
criteria, [41-43, 54, 60-62, 65-67, 71, 72, 74-79], one study used DSM-III [68], five studies did not explicitly 
specify whether the International Classification of Diseases (ICD) or DSM was used [44, 45, 50, 63,70]. 
All included studies used ICD or DSM criteria for diagnosis and 14 different validated instruments to 
assess mental disorders in children and adults (see Table 3.1). To assess anxiety in children, instruments 
employed were the Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI Kid) 
[42, 43], the University of California at Los Angeles Post-traumatic Stress Disorder Reaction Index for 
DSM-IV) for children [62], parts I and IV of the Harvard Trauma Questionnaire (HTQ) with a cut-off score 
≥2.0 to screen PTSD [50], and the five-item version of the Screen for Child Anxiety Related Disorders 
(SCARED) with a cut off score of ≥4 [63]. In adults, the five studies that assessed anxiety disorders 
(PTSD and GAD) employed the MINI-Plus [61], the Generalized Anxiety Disorder Questionnaire for DSM-
IV (GAD-Q-IV) [54], the Posttraumatic Diagnostic Scale (PDS) [62], parts I and IV of the HTQ with a cut-
off score ≥2.0 to screen positive for PTSD [50], and the ICD-11 Trauma Questionnaire (ICD-TQ) for PTSD 
and Complex PTSD [67]. 
Depression in children was assessed using MINI Kid [43], the Children’s Depression Inventory (CDI) with 
a score cut-off ≥3 [62], the Hopkins Symptom Checklist-25 (HSCL-25) with a cut-off score ≥1.75 [50], 
and the Short Mood and Feelings Questionnaire – Child self-report (MFQ-C) with a cut-off score ≥10 [63]. 
In adults (Table 3.1), 11 included studies used the Mini-International Neuropsychiatric Interview (MINI) 
[41, 45, 60, 65, 66, 71, 72, 74, 76-78], three used the Patient Health Questionnaire (PHQ-9) with a cut-
off score of ≥ 10 [68, 75, 79], four used the Hopkins Symptom Checklist-25 (HSCL-25) depression module 
that consist of 15-items with a cut-off score ≥1.65 and ≥1.75 [44, 50, 62, 73] and one used the Edinburgh 
Postnatal Depression Scale (EPDS) with a cut-off score ≥10 [70]. 
The included studies were from 19 districts (Table 3.1) across the four (Central, Eastern, Northern and 
Western) regions of Uganda. Four studies (five articles) were exclusively from the Northern region [50, 
60-62, 67], one from the Eastern region [44], four from the Western region [66, 69, 70, 73] and 11 from 
the Central region [41, 54, 65, 68, 71, 74, 76-79]. Four studies encompassed more than one region; one 
study was conducted across the Northern, Central and Western regions [45], one from the Northern and 
Western regions [63], one from the Central and Eastern regions [75] and one study (two articles) from the 
Northern and Eastern regions of Uganda [42, 43]. Of the included studies that investigated mental 
disorders in children, all the participants were sampled from community settings [42, 43, 50, 62, 63, 69], 
while for those studies informing prevalence of mental disorders in adults, nine sampled participants from 
community settings [44, 50, 54, 60-62, 67, 72, 73, 79] and 12 from health facility settings [41, 45, 65, 66, 
68, 70, 71, 74-78]. 
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Table 3.1: Characteristics of included studies reporting prevalence of mental disorders in children and adults in Uganda 
First author, 
publication year  
Ugandan 
district 









Cases Proportion (95% C.I.) 
Irvine, 2012 [69] Rukungiri Households in 
the community 
Cross-sectional AIDS, orphaned, 
non-AIDS, orphaned 
and non-orphaned 
PTSD TSCC 726 56 7.7%  
(95% C.I 5.8-9.7%) 






Cross-sectional Children aged 3-19 















(95% C.I 24.5-28.8%) 
1.5%  
(95% C.I 1.0-2.2%) 
0.7% 
(95% C.I 0.4-1.2%) 








Cross-sectional Children aged 3-19 
years in UNICEF 
child protection 
project 
MDD MINI Kid 1587 136 8.6%  















Aged 13-17 years 

































(95% C.I 3.0-6.7%) 
6.6%  
(95% C.I 4.5-8.8%) 
13.6%  
(95% C.I 12.0-15.1%) 
17.4%  
(95% C.I 15.7-19.1%) 
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Cross-sectional Community in post-
war area: children 






































(95% C.I 1.8-4.9%) 
38.2%  
(95% C.I 34.0-42.4%) 
 
9.9% 
(95% C.I 7.4-12.5%) 
14.4%  
(95% C.I 11.4-17.5%) 




Cross-sectional South Sudanese 
refugee adolescents 






score ≥10  
SCARED 
cut-off 





(95% C.I 31.7-40.4%) 
30.2% 
 (95% C.I 26.1-34.4%) 




Cohort baseline HIV positive clients 
new to the clinic 
Depression PHQ-9 602 77 12.8%  
(95% C.I 10.1-15.5%) 




HIV clinic in 
Kigungu HC III 
and Entebbe 
Hospital 
Cross-sectional People living with 
HIV enrolled for care 
MDD MINI-Plus 618 50 8.1%  
(95% C.I 5.9-10.2%) 




Not reported People living with 

















Akena et al., 2012[65] Kampala HIV clinic Cross-sectional People living with 
HIV/AIDS 
MDD MINI-Plus 368 64 17.4%  
(95% C.I 13.5-21.6%) 
Kakyo et al., 2012[70] Kabarole Postnatal clinic Cross-sectional Postnatal mothers 
with baby ≤ 12 
weeks attending 





off score ≥ 
10  
202 87 43.1%  
(95% C.I 36.4-50.0%) 
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Cross-sectional Vulnerable people 






1561 664 42.5%  
(95% C.I 40.1-45.0%) 




Case-control People living with 














(95% C.I 9.0-15.5%) 
23.8%  
(95% C.I 19.8-28.2%) 
Akena et al., 2015[45] Gulu 
Kampala 
Mbarara 
Diabetic clinic Cross-sectional Confirmed diabetic 
mellitus patients who 
have attended clinic 
for at least 2 months 
MDD MINI-Plus 437 152 34.8%  
(95% C.I 30.3-39.2%) 
Ashaba et al., 2015[66] Mbarara Hospital wards Case-control Mothers of 
malnourished 
children under 5 
(cases), and other 
chronic conditions 
(control) 
MDD MINI-Plus 166 45 27.1%  
(95% C.I 20.9-34.3%) 
42% in cases and 12% in 
control 
Dokkedah et al., 
2015[67] 
Gulu Community at 
household level 
in 2014 
Cross-sectional Formerly adducted 
and never abducted 
by Lord’s Resistance 




ICD-TQ 314 115 36.6% 
(95% C.I 31.3-42.0%) 
46.3% in formerly abducted 
and 29.7% in never abducted 





Cross-sectional Post stroke clients 
with single episode 
of stroke confirmed 




73 23 31.5%  
(95% C.I 22.0-42.9%) 








Cross-sectional Residents of the 
village, 18 years or 
older 
MDD MINI-Plus 2361 582 24.7%  
(95% C.I 22.9-26.4%) 
54 
 








Cross-sectional Residents of the 












(95% C.I 10.5-13.1%) 
14.8%  
(95% C.I 13.4-16.3%) 




Cross-sectional  People living with 
HIV/AIDS attending 
clinic 
Depression MINI-Plus 345 34 9.9% (4.9% had DPC)  
(95% C.I-7.1-13.5%) 









nested in cohort 
Older people (50+ 
with and without 
HIV/AIDS impact) 
study cohort 
MDD MINI-Plus 468 43 9.2%  
(95% C.I 6.7-12.2%) 






Cross-sectional All residents of 





1499 268 17.9%  
(95% C.I 15.9-19.8%) 
Huang et al., 2017[79] Kampala Community 
household 
survey 
Cross-sectional Parents of children 
enrolled in pre-




score ≥10  
303 85 28.1%  
(95% C.I 23.3-33.4%) 






Cross-sectional People living with 
HIV/AIDS who are 
ART naïve  
MDD MINI-Plus 899 126 14.0%  
(95% C.I 11.7-16.3%) 




Cross-sectional First year 
undergraduate  
GAD GAD-Q-IV 387 112 28.9%  
(95% C.I 24.6-33.7%) 







nested in cohort 
People living with 
HIV/AIDS who are 
ART naïve  
MDD MINI-Plus 201 62 30.8%  
(95% C.I 24.8-37.5%) 
AIDS=Acquired Immune Deficiency Syndrome; ART=antiretroviral therapy; CDI=Children’s Depression Inventory; C.I=confidence interval, DPC=depression pain comorbidity; EPDS=Edinburgh Postpartum Depression Scale; GAD-Q-
IV=Generalised Anxiety Disorder Questionnaire for DSM IV;HIV=Human Immunodeficiency Virus; HTQ=Harvard Trauma Questionnaire; 15-items HSCL or DHSCL-25= Depression module of Hopkins Symptom Checklist-25; ICD-TQ=ICD-11 
Trauma Questionnaire; MDD=Major Depressive Disorders; MFQ-C=Short Mood and Feelings Questionnaire-Child Self Report; MINI=Mini International Neuropsychiatric Interview; MINI Kid= Mini International Neuropsychiatric Interview for 
children and adolescents; PDS=Posttraumatic Diagnostic Scale; PHQ-9=Patient Health Questionnaire; PTSD=post-traumatic stress disorder; SCARED= 5-item version of the Screen for Child Anxiety Related Disorders; TSCC=Trauma 
Symptoms Checklist for Children; UNICEF= United Nation Children’s Fund; UPID=University of California at Los Angeles PTSD Reaction Index for DSM-IV. 
* The study by Abbo et al. reported multiple specific anxiety disorders including: specific phobia, 15.8% (95% C.I 14.0-17.6); PTSD, 6.6%(95% CI 5.4-8.0); separation anxiety disorder, 5.8% (95% CI 4.7-7.1); social phobia, 5.2% (95% C.I 4.2-
6.4); agoraphobia, 3.8% (95% C.I 2.9-4.8); panic disorder, 3.0% (95% C.I 2.2-4.0); GAD 1.4%(95% C.I 0.9-2.1); obsessive compulsive disorder, 0.6% (95% C.I 0.3-1.1); and adjustment disorder 0.5% (0.2-1).
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3.3.3 Methodological quality of included studies 
Overall, the methodological quality assessment for the included studies was high (Table 3.2). Individually, 
10 studies were given high-quality scores (eight to nine ‘yes’ ratings), 12 studies scored seven ‘yes’ 
ratings and only two scored six ‘yes’ ratings.  Of the studies investigating mental disorders in children, all 
but one sampled the target population appropriately (Table 3.2; Q1 and Q2). Adequacy of the sample 
size was unclear in two of the studies [62, 63]. Most studies fulfilled criteria aligned with the measurement 
of prevalence in children; a similar pattern was also observed in studies involving adults. However, in a 
subset of studies it was ‘unclear’ if the data collectors were trained or any mechanism to ensure 
consistency among data collectors was followed (Table 3.2; Q7). The majority of studies used appropriate 





Table 3.2 Methodological quality of included studies 
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Score 
Irvine, 2012[69] Y Y Y Y Y Y U Y Y 8 
Abbo et al., 2013[42] 
Kinyanda et al., 2013[43]                    
Y Y Y Y Y Y Y Y Y 9 
Malamba et al., 2016[50]* Y Y Y Y Y Y Y Y Y 9 
Saile et al., 2016[62]* Y N U Y Y Y Y Y Y 7 
Meyer et al., 2017[63] Y Y U Y Y Y Y U Y 7 
% Score children 100 80 60 100 100 100 80 80 100  
Wagner et al., 2011[75] Y Y N Y Y Y U Y Y 7 
Kinyanda et al., 2011[71] Y N U Y Y Y Y Y Y 7 
Nakimuli-Mpungu et al., 
2011[76] 
Y U N Y Y Y Y Y Y 7 
Akena et al., 2012[65] Y Y U Y Y Y Y Y Y 8 
Kakyo et al., 2012[70]                    Y Y N Y Y Y U Y Y 7 
Kinyanda et al., 2012[44] Y Y Y Y Y Y Y U Y 8 
Nakimuli-Mpungu et al., 
2013[77]                  
Y U N Y Y Y Y Y Y 7 
Akena et al., 2015[45] Y Y N Y Y Y Y N Y 7 
Ashaba et al., 2015[66] Y U Y Y Y Y Y Y Y 8 
Dokkedah et al., 2015[67] Y Y U Y Y Y U N Y 6 
Gyagenda et al., 2015[68] Y Y U Y Y Y U Y Y 7 
Mugisha et al., 2015a[60]; 
Mugisha et al., 2015b[61] 
Y Y Y Y Y Y Y Y Y 9 
Mwesiga et al., 2015[41] Y U N Y Y Y Y Y Y 7 
Perkins, 2016[73] Y Y Y U Y Y Y Y Y 8 
Kinyanda et al., 2016[72] Y U U Y Y Y U Y Y 6 
Huang et al., 2017[79] Y Y U Y Y Y Y U Y 7 
Kinyanda et al., 2017[74] Y Y U Y Y Y Y Y Y 8 
Umeh and Bangirana, 
2017[54] 
Y Y Y Y Y Y U Y Y 8 
Musinguzi et al., 2018[78] Y Y U Y Y Y Y U Y 7 
% Score adults 100 68.4 26.3 94.7 100 100 68.4 73.7 100  
Overall % quality scores 100 70.8 33.3 95.8 100 100 70.8 75.0 100  
Key: Q stands for question/criteria, Q1. Was the sample frame appropriate to address the target population? Q2. Were study participants 
sampled in an appropriate way? Q3. Was the sample size adequate? Q4. Were the study subjects and settings described in detail? Q5. 
Was the data analysis conducted with sufficient coverage of the identified sample? Q6. Were valid methods used for the identification of 
the condition? Q7. Was the condition measured in a standard, reliable way for all participants? Q8. Was there appropriate statistical 
analysis? Q9. Was the response rate adequate, and if not, was the low response rate managed appropriately? Y – Yes, U – Unclear, N 







3.3.4 Prevalence of mental disorders among children and adults in Uganda  
The pooled prevalence estimate of mental disorders was 22.9% (95% C.I 11.0%-34.9%; I2= 99.1%; χ2 p 
<0.001 Figure 3.2[a]) in 3,803 children and 24.2% (95% C.I 19.8% – 28.6%; I2 97.8%, χ2 p<0.001 Figure 
3.2[b]) in 14,091 adults assessed.  In adults, included studies published from 2012 to 2015 showed a 
generally higher prevalence compared to the remainder of the included publication period. Specific mental 
disorders identified and included in these analyses were anxiety disorders and depression. 
 
Figure 3.2 Meta-analysis of prevalence estimates of mental disorders in (a) children and (b) adults in Uganda, presented by year of 
publication. Mental disorders include anxiety disorders (e.g. post-traumatic stress disorder, specific phobia, separation anxiety disorder, 







3.3.5 Anxiety disorders in children and adults 
The pooled prevalence estimate of anxiety disorders in children was 14.4% (95% C.I 4.9%-24.0%, I2 = 
99.1%; χ2 p<0.001; Figure 3.3[a]). Included in these results were the four studies [42, 50, 62, 69] that 
reported prevalence of PSTD in children and the pooled estimate was 5.6% (95% C.I 3.7%-7.5%; I2= 
81%; χ2 p <0.001), with one reporting probable anxiety disorders [63]. In addition to PTSD, a single study 
(n=1587 children)[42] reported specific phobias, 15.8% (95% C.I 14.0%-17.6%); separation anxiety 
disorder, 5.8% (95% CI 4.7%-7.1%); social phobia, 5.2% (95% C.I 4.2%-6.4%); agoraphobia, 3.8% (95% 
C.I 2.9%-4.8%); panic disorder, 3.0% (95% C.I 2.2%-4.0%); GAD 1.4% (95% C.I 0.9%-2.1%); obsessive 
compulsive disorder, 0.6% (95% C.I 0.3%-1.1%); and adjustment disorder 0.5% (0.2%-1.0%).  
The pooled prevalence of anxiety disorders (GAD and PTSD) in adults was 20.2% (95% C.I 14.5%-25.9% 






Figure 3.3. Meta-analysis of prevalence of anxiety disorders in (a) children and (b) adults in Uganda, presented by year of publication. 
Anxiety disorders include post-traumatic stress disorder, specific phobia, separation anxiety, generalized anxiety disorder and others 
reported by Abbo et al., 2013. 
 
3.3.6 Depressive disorders in children and adults 
The pooled point prevalence estimate of depressive disorders in children was 22.2% (95% C.I 9.2%-
35.2%; I2 = 99.0%; χ2 p<0.001; Figure 3.4[a]). In adults, the pooled prevalence of current depressive 
disorders was 21.2% (95% C.I 16.8%-25.6%; I2 = 97.7%; χ2 p<0.001 Figure 3.4[b]). In addition to the 
current prevalence of depressive disorders in adults, two studies, [76, 77] involving 900 participants also 
provided lifetime prevalence. In these studies, the prevalence estimate of lifetime depressive disorders 
was 19.4% (95% C.I 11.0%-27.7%; I2 = 90.3%; χ2 p=0.001), and the current depressive disorders 
prevalence was 12.8% [76, 77]. Overall, lifetime prevalence unexpectedly appeared lower than the pooled 






Figure 3.4 Meta-analysis of prevalence of depressive disorders in (a) children and (b) adults in Uganda, presented by year of publication. 
Depressive disorders include major depressive disorder, dysthymia and bipolar disorder. 
3.3.7 Other mental disorders 
One study reported psychotic disorder syndrome (n=24) 1.5% (95% C.I 1.0%-2.2%) and eating disorders 
(n=11) 0.7% (95% C.I 0.4%-1.2%) in 1587 children from four districts in North and Eastern Uganda [42, 
43].  
3.3.8 Subgroup analysis 
I2 statistic and χ2 p-value were used to assess the presence and degree of heterogeneity across studies. 





to explore heterogeneity in children as all the included studies used different instruments and were all 
conducted in community settings (Table 3.1). 
To explore the substantial statistical heterogeneity observed across all estimates in adults (Figures 3.2 
[b] to 3.4 [b]); I2 =98-99% χ2 p<0.001), studies were grouped and analyzed according to the instrument 
used to measure the identified disorders. On this basis, prevalence estimates between groups ranged 
from 21.6% for the MINI (95% C.I 15.9%-27.4%; I2 = 97.4%; χ2 p<0.001; 11 studies, n=6763), 23.1% for 
the HSCL-25 (95% C.I 11.4%-34.7%; I2 = 99.1%; χ2 p<0.001; four studies, n=5446), and 23.5% for the 
PHQ-9 (95% C.I 10.8%-36.2%); I2 = 94.3%; χ2 p<0.001; three studies, n=978). For other instruments 
(EPDS, GAD-Q-IV, ICD-11), prevalence was 35.9% (95% C.I 28.0%-43.8%); I2 = 84.0%; χ2 p=0.002; 
three studies, n=903). 
A further subgroup analysis was performed analyzing prevalence of mental disorders in adults, according 
to the setting from which they were sampled (Table 3.1). Prevalence in adults from a health facility was 
24.1% (95% C.I 18.1%-30.2%; I² =96.8%, χ2 p<0.001; 12 studies, 4811 participants) and 24.3% in the 
community (95% C.I 17.7%-30.9%; I²=98.3%, χ2 p<0.001; nine studies, 9279 participants).  
The influence of sample size on the observed heterogeneity was also investigated. Thirteen studies 
included in the analysis had a sample size ≤500. The pooled prevalence for studies with a sample size 
<300 was 33.2% (95% C.I 25.9%-40.6%; I2 = 74.5%; χ2 p=0.008; four studies, n=642). While the pooled 
prevalence estimate from studies with a sample size ranging from 300 to 500 was 25.4% (95% C.I 17.7%-
31.1%; I2 = 97.1%; χ2 p<0.001; nine studies, n=3522) and 19.0% (95% C.I 12.3%-25.7%; I2 = 98.7%; χ2 
p<0.001; eight studies, n=9927) for studies with a sample size >500.  
3.3.9 Summary of findings and certainty of evidence  
Table 3.3 presents the GRADE Summary of Findings for the prevalence of mental disorders in Uganda, 
indicating moderate certainty. For all the outcomes assessed in both children and adults, certainty in 
estimates was affected by the inconsistency judged by heterogeneity (I2) and precision (confidence 
interval) across studies. 
Table 3.3. Summary of Findings: prevalence of mental disorders in Uganda using the GRADE 
approach 
















































































































No concerns No concerns 
Number of 
participants 
With condition 876 3276 661 881 533 2878 


















































Certainty Moderate Moderate Moderate Moderate Moderate Moderate 
GRADE: Grading of Recommendations, Assessment, Development and Evaluations 
C.I: confidence interval, I 2: I-squared statistic 
1 Some sampling issues with the Saile et al. 2016 but only one study contributed 19.8% weight to meta-analysis, hence level of certainty 
was not downgraded 
2 Serious concerns due to considerable heterogeneity (I 2 ≥90%, p<0.001), hence level of certainty was downgraded to moderate for 
inconsistency.  
3 Inclusion of two studies with participants from refugee and orphan backgrounds; our judgement was that the prevalence did not differ much, 
and this body of evidence was considered to be representative of the overall population of Uganda. One study also had overlapping age 
strata 14-19 (that included adults 18 and 19 years) but was considered insignificant and therefore the level of certainty was not downgraded 
for indirectness. 
4 Serious concerns due to wide confidence interval, however level of certainty was not downgraded further; see no. 2 above. 
5 Some sampling issues with the Kakyo et al. 2012 and Saile et al. 2016, however, each contributed 4.7% and 5.1% weights, respectively, 
to meta-analysis, hence level of certainty was not downgraded 
6 Serious concerns due to considerable heterogeneity (I 2 ≥90%, p<0.001) in the pooled estimates which could not be explained by the 
subgroup analysis (sample size, participants from healthcare and community settings, and assessment instruments used). Hence level of 
certainty was downgraded from high to moderate. 
7 One study had an overlapping age stratum 15-24 that included children (under 18 years). However, instruments used were appropriate, 







The results of this review reveal that mental disorders affect a substantial proportion of the Ugandan 
population. Nearly one in four children and adults are affected by mental disorders. Across the general 
population, this corresponds to approximately nine million Ugandans, of whom 4.9 million are children. 
Major depressive disorders are the most prevalent condition, followed by anxiety disorders. In both 
children and adults, the review did not find studies that captured other types of mental disorders, 
particularly those with onset in childhood [1, 2]. There was no difference in the prevalence of identified 
disorders among adults, irrespective of where they were sampled from, that is, health facilities or 
community settings. 
Overall, the findings of this review support the notion that mental disorders begin to occur early in life and 
continue to manifest in adulthood [23, 24]. The prevalence of mental disorders in Uganda in this review 
is considerably higher than that observed globally. Worldwide, the prevalence estimate of mental 
disorders is reported to be under 20%, and depression and anxiety disorders are more prevalent among 
populations under the age of 30 years [7, 15, 25]. These age group comprise the largest proportion 
(approximately 88%) of Uganda population. [27, 28]. 
There was variability in the regional coverage of prevalence data across Uganda. In an available review 
conducted in Uganda, the majority of studies included were from the Central region (including the capital 
city Kampala) and the Acholi subregion of Northern Uganda [12]. Cultural, social and economic factors 
that could influence the prevalence of mental disorders are diverse and may differ considerably between 
regions of Uganda [16, 17, 28]. For example, the Northern region of Uganda has recently emerged from 
major social and economic disruptions because of prolonged armed conflicts [30, 31], compared with the 
Central and Western regions. However, the effects of conflict are unclear, as one study showed that 
participants from Gulu, which has been the most affected by conflict, had a lower prevalence of anxiety 
than the three districts of Lira, Kaberamaido and Tororo [42]. At face value, this appears inconsistent with 
research conducted in other settings that suggest people in conflict areas have a higher prevalence of 
anxiety and depressive disorders [20-22]. This review restricted eligibility of studies to those conducted 
from 2010 or later, which was three or more years after the Lord’s Resistance Army insurgency, which 
may explain this apparent discrepancy.  
On the other hand, most included studies from the Central and Western regions of Uganda involved 





physical illness, while those from the Northern and Eastern regions were community based samples. The 
subgroup assessment of the influence of study locations (health facilities and community settings) on the 
pooled prevalence of any mental disorders showed no differences. Notwithstanding, within the timeframe 
of the studies informing this review, several factors associated with depression and anxiety disorders in 
Uganda were documented. These factors included experiencing negative life events (for example, serious 
illness, violence and abuse) [41-43, 50, 54, 60-63, 67, 69-71] self-perceived lack of social support [41-43, 
60-63, 66, 68, 71, 76, 77], and living arrangements (single parents, non-biological parents, having many 
siblings) [42, 43, 50, 54, 69]. Other factors specific to adults were low socio-economic index (unpaid work 
such as farming, fishing, micro-enterprise/trading), low level of education [45, 65, 72, 74-76, 78] and food 
insecurity (especially among women) [60, 61, 71, 73, 79]. These factors were congruent with individual 
factors (age, physical health and psychological function), contextual factors (social environment) and 
family profiles documented by previous research [2, 10, 17]. 
Literature suggests that people with mental disorders experience worse health outcomes, compared to 
the general population [3-5, 7]. Yet, limited resources are devoted in response to mental health needs 
[14].  The findings should motivate policy makers and health service planners in Uganda to ensure 
adequate, safe and supportive services, including diagnostic, preventive, treatment and rehabilitative 
health services, are made accessible to people with mental disorders. The mental health status of children 
and adults should be assessed and treated when people are seeking care for other reasons or caring for 
relatives. The WHO mhGAP and WHO Mental Health Action Plan provide useful information as a starting 
point [34, 35], and encompass issues of whether to strengthen integration of health care, training of health 
workers or further research to establish the nature and impact of comorbidity. 
3.4.1 Strengths and limitations 
This systematic review had strict predefined inclusion criteria and only included studies that assessed 
clinically relevant symptoms [2] such as those of MDD. There were a number of limitations that must be 
acknowledged. Firstly, we were aware that some individuals with minor depression were excluded from 
the analyses undertaken in the review. In addition, most of the studies did not investigate the prevalence 
estimates for disorders such as psychotic disorders, eating disorders and others. The present review is 
likely to underestimate the overall true prevalence of mental disorders in Uganda.  
Secondly, the meta-analysis identified substantial inter-study heterogeneity across all random effect 





prevalence of mental disorders in children and adolescents [8]. Experts have argued that heterogeneity 
in observational studies should be expected and investigated [36, 58, 59]. Heterogeneity as measured by 
I2 is sensitive to study precision which is often influenced by sample size and the total number of studies 
included in the model [59]. In the current review, the sample size and number of studies included in the 
analyses varied substantially. Subgroup analysis failed to explain the observed heterogeneity. However, 
some relevant factors such as socio-economic status and gender were not analyzed in subgroups as 
specified a priori [38] due to incomplete reporting and non-uniform data in the included studies. In addition, 
a number of the included studies were conducted on populations with special characteristics to explore 
associations of mental disorders with other variables, such as HIV, diabetes, child protection interventions 
and food insecurity applicable across all regions of Uganda. The possibility that the observed 
heterogeneity may have been due to differences in participant characteristics or other unknown factors 
cannot be ruled out.  
Thirdly, there was wide variability in the geographical coverage of data used to calculate the pooled 
prevalence estimates of mental disorders in this study. None of the studies included in this systematic 
review investigated the prevalence of mental disorders countrywide.  
These limitations highlight the need for further investigation of prevalence of mental disorders in Uganda, 
taking into account study methods, measurement procedures and case definitions. Ideally, large scale 
countrywide studies in Uganda, assessing mental disorders in appropriately sampled populations using 
consistent methodologies, are required to enable the formulation of any strong conclusion. In addition, 
future systematic reviews pertinent to Uganda should consider investigating a wider range of mental 
disorders to include disorders common in childhood (<17 years), and neurological and substance use 
disorders.  
3.4.2 Conclusion 
The results of this systematic review and meta-analysis indicate that approximately one in four children 
and adults in Uganda meet the criteria for clinically relevant symptoms of mental disorders, predominantly 
depression and anxiety disorders. There is limited evidence regarding the prevalence of other mental 
disorders in Uganda. Despite a substantial level of heterogeneity in the analyses, the pooled prevalence 
estimates provide an important addition in mental health epidemiology in Uganda. The findings provide 
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Appendix 3.I: Search strategy employed for specific data sources  
The JBI empirical approach for conducting an optimized search strategy for identifying papers on the 
prevalence of mental disorders in Uganda was used. In the first step, 15 articles published since 2015 
deemed to be critical papers of interest for this review were identified. This set of papers were used to 
generate and improve search strategies in order to maximize their sensitivity and specificity for identifying 
relevant articles in separate databases: PubMed, PsycINFO, Embase, Scopus and Web of Science. The 
identified search terms were used to develop keywords for searching in Google Scholar and other gray 
literature sources, including websites of the Ugandan Ministry of Health. The search strategy was 
developed in PubMed, and iterative changes were made to enable optimal searching in the other 
databases, for example, using the all field (.exp, de, syn or mj) search field in Embase; in PsycINFO we 
used the multi-purpose (.mp or exp) field, as described below. We drew on existing optimized search 
strategies to identify mental health content in the general medical abstracting databases. Mental disorders 
were searched, using a combination of exp mental disorders AND mental disorders/ep or 
psychopathology OR Psychiatry/ep OR psychiatric. To identify studies reporting prevalence, we 
commenced with the basic search terms “prevalence” or “epidemiology” but were unable to obtain 
adequate sensitivity and specificity estimates. We then applied an advanced search strategy combined 
with this initial search to increase the specificity of searches without losing sensitivity. This was achieved 
by using one of two search strings to narrow the above search outcomes: 
The initial search in PubMed was undertaken on 20 October 2017 (test search) and then updated for 
publications between 2 May 2018 and 4 May 2018. The full search strings are provided in supplementary 
data below. The search terms and strategies were customised for each data source. The numbering used 
in the first column represents topics searched. Number 1 represents the topic mental disorders; number 
2 is the condition of interest – prevalence or epidemiology, and number 3 represents the geographical 
setting of Uganda. Number 4 is the advanced search strategy that combined the search topic using 
Boolean “AND” and applying a search limit to the year in which the paper was published. 
PubMed search strategy 
1 "Mental disorders"[MeSH Terms]  OR "mental disorders"[major] OR "mental disorders"[All 
Fields] OR "mental disorder"[All Fields] OR "mental disorders"[All Fields] OR "Mentally ill 
persons"[MeSH Terms] OR "mentally ill persons"[All Fields] AND "mentally ill person"[All 





"psychopathology"[All Fields] OR "psychiatry"[MeSH Terms] OR "psychiatry"[All Fields] OR 
"psychiatric"[All Fields] OR "Child psychiatry"[MeSH terms] OR "diagnostic and statistical 
manual of mental disorders"[MeSH Terms] 
2 "Prevalence"[MeSH Terms] OR "epidemiology"[All Fields] OR "prevalence"[All Fields] OR 
"Epidemiology"[MeSH] 
3 "Uganda"[MeSH Terms] OR Uganda [All Fields] 
4 #1 AND #2 AND #3 AND Pub ("2010/01/01"[PDAT] : "2018/04/30"[PDAT])=199 
Embase search strategy 
1. 'mental disease'/mj OR 'mental disease'/exp OR 'mental patient'/exp OR 'mental patient'/de 
OR 'mental patient'/syn OR 'child psychiatry'/exp OR ‘Psychopathology’/exp 
2. 'prevalence'/mj OR ‘prevalence’/exp OR 'epidemiology'/exp 
3. ‘Uganda'/exp OR 'Uganda'/de 
4. #1 AND #2 AND #3 AND limit PY:2010-2018=220 
PsycINFO search strategy 
1 Psychological disorder.mp. OR psychiatric disorders.mp. OR exp Mental 
Disorders/ OR mental disorders.mp. 
2 Prevalence.mp. OR epidemiology.mp. 
3 Uganda 
4 #1 AND #2 AND #3 Limit 2010-2018(current)=42 
Scopus search strategy 
1 "Mental disorders"  OR  "mental disease"  OR  "Psychiatric disorders"  OR  "Mentally ill 
persons"  OR  "Psychopathology"  OR  "psychiatry"  OR  "Child psychiatry" OR "diagnostic 
and statistical manual of mental disorders" 
2 "prevalence"  OR  "epidemiology"  
3 "Uganda"  
4 #1 AND #2 AND # 3 AND PUBYEAR>2009=41 
Web of Science search strategy 
1 ("mental disorders" OR "Mentally ill persons" OR "Psychopathology" OR "psychiatry" OR "Child 
psychiatry" OR "psychiatric" OR "diagnostic and statistical manual of mental disorders") 






4 #1 AND #2 AND #3 Limit by time Span 2010-2018=68 
Google Scholar search strategy 
Advanced search to find relevant articles with all of the words "Uganda" with at least one of the words 
"Mental disorders" OR "mental disease" OR "Psychiatric disorders" OR "Mentally ill persons" OR 
"Psychopathology" OR "psychiatry" OR "Child psychiatry" AND  “prevalence” anywhere in the article. 
Limit to return articles dated between 2010 and 2018=53 
Cut-off at 6 as studies following were not relevant. 
ProQuest search strategy 
ab((Mental disorders OR mentally ill persons OR mental disease OR Psychopathology OR Psychiatric 
OR child psychiatry)) AND ab((prevalence OR epidemiology)) AND noft((Uganda)) limit from 1/1/2010 to 
30/4/2018 =5 
Key: ab-abstracts, noft-anywhere not in fulltext.  
The Republic of Uganda Ministry of Health Knowledge Management Portal search strategy 
http://library.health.go.ug/  
Prevalence OR Epidemiology of mental disorders and Uganda filter by date of publication 2010-2018=0 
WHO iris search strategy 
http://apps.who.int/iris/simple-search?query  
Prevalence OR Epidemiology of mental disorders and Uganda filter by date of publication 2010-2018=0 
Reference list of eligible studies  












Appendix 3.II: Response to reviewers’ comments 
Provided below is the response to reviewers for the initial submission to the Journal of Affective Disorders 
(Ref: JAD_2019_2834)  
Response to reviewers 
Reviewer 1 
 
This is a systematic review of mental disorder prevalence in Uganda. The systematic review is reported 
in compliance with PRISMA and had an a priori registered protocol in PROSPERO. The literature 
search strategy is presented in a supplementary file. It seeks grey literature sources and also is 
supplemented by a manual search. The search is restricted to studies published later than 2010. 
Other methodological safeguards have been included. There is an independent review of quality by two 
reviewers and also duplicate data extraction. They also do GRADE ratings. 
I am not very comfortable with the logit transformation employed for the meta-analysis. With meta-
analysis of proportions, the standard error is restricted due to the minimum and maximum values of a 
proportion, which can introduce bias into pooled estimates deriving form inverse variance weighting. 
Normally, this problem is addressed using a variance stabilizing transformation, e.g. the Freeman-Tukey 
Double Arcsine Transformation. The authors cite Barendregt to support their use of the logit 
transformation, but quoting Barendregt: “The double arcsine transformation addresses both the problem 
of confidence limits outside the 0..1 range and that of variance instability, and it is therefore preferred 
over the logit transformation” 
Response: We thank the reviewer for the overall comments and as well as raising a pertinent 
concern over methodological approach employed in our review. 
We agree that Logit transformation tend to suffer from the correlation between the estimate of the 
proportions and its variance especially when some studies had zero event reported. We have 
explored reviewer concerns using the same software we had used before, choosing Freeman-
Tukey Transformed proportion metric as data type for analysis. The results (study weight, 
standard error, and pooled prevalence estimate) of analysis using Freeman-Tukey transformed 
proportion were comparable with that of Logit transformed proportion. The agreement in results 





in all the included studies were large, such that the two-transformation techniques converge. In 
the meta-analysis, the smallest number of cases of a mental disorder reported by individual study 
was 23 and highest was 664. From the perspective of proportion, the lowest prevalence reported 
was 8.1% and the highest was 43.1%. Therefore, we have not made changes to method of data 
transformation from Logit to Freeman-Tukey Double Arcsine as it appears to change little and in 
keeping with the a priori protocol. 
In the introduction, there is reference to a projected increase in prevalence in Uganda - but secular trends 
in prevalence do not seem to have been evaluated (e.g. the forest plots are sorted alphabetically rather 
than by year, no meta-regression is undertaken). 
Response: We agree that trends in prevalence of mental disorders were not evaluated. The aim 
of this review was to establish the most recent prevalence estimate of mental disorders; this 
reasoning also formed the basis for limiting the search to 2010. However, we have re-analysed 
the data organised by year of publication (line 145-146, page 7). The revised results (forest-plots) 
are in Figure 3.2, Figure 3.3, and Figure 3.4. We have also made changes in Table 3.1 and Table 
3.2, arranged by year of publication. 
The visual inspection of the forest plot shows high inter-study variability. Studies published from 
2012 to 2015 particularly revealed distinct prevalence patterns of mental disorders, this may be 
due to the participants characteristics (sampling frame) and sample size. For example, most of 
the included studies published from 2012-2015 investigated prevalence in diabetic patients, 
mothers of children admitted in hospital due to malnutrition, stroke patients and others. 
Consequently, participants were subject to a known adverse life events and therefore at risk for 
psychological disorders. This could explain why the prevalence reported by individual study 
during this period was much higher and the sample size were smaller. 
To explore the observed heterogeneity in the pooled prevalence estimate, we only used subgroup 
(instruments, site from which participants were selected and sample size) analysis instead of 
meta-regression. We have added the results of subgroup analysis for sample size on line 322 - 
337 (page 14-15) Section 3.3.8 of the manuscript. 
The estimates are very high – possibly reflecting the inclusion both of diagnostic instruments, screening 
instruments and symptom rating scales. For example, the pooled point prevalence of depressive 





studies using diagnostic interviews. It seems that none of the included studies included a full-length 
structured or semi-structured diagnostic interview (the MINI is a brief interview that tends to overestimate 
prevalence, the scales employed are not diagnostic instruments at all). The authors state that the results 
are consistent with those of the GBD, but Ferrari et al. (2011) reported a global prevalence of major 
depression of 4.7%. The extent of heterogeneity seen in the forest plots is excessive and draws into 
question the value of the pooled estimates. In Figure 3.2b only 3 studies provide confidence intervals that 
are consistent with the estimated pooled prevalence. They are pooling apples and oranges together. I 
think there should be more focus on explaining the heterogeneity and less on pooling. 
Response: As stated in our response above, we aimed to synthesise appropriately derived 
prevalence estimate of mental disorders in Uganda. Heterogeneity was investigated through 
subgroup analysis stipulated a priori. 
We agree regarding the overall prevalence combined results of studies using different 
assessment instruments including those using diagnostic and screening instruments. We 
explored how each of these instruments influenced the pooled prevalence estimates in adults 
and the observed heterogeneity. In this case, the screening instruments used to ascertain mental 
disorders were PHQ-9 (n=3), HSCL-25 (n=4) and others (EPDS, ICD-11 and GAD-Q-IV) and the 
standard structured diagnostic instrument MINI (n=11). The analysis showed that instruments 
grouped as others had the highest prevalence 35.9% (95% CI 28.0%-43.8%) (this has been 
added in the manuscript line 315 - 316 (page 14). The results of other instruments were closer to 
pooled prevalence estimates. 
We have expanded the results of the subgroups analysis to include sample size in the manuscript 
in Section 3.3.8, line 322 – 328 (page 14-15) of the manuscript. The method Section 3.2.6 of the 
manuscript has been updated in line 160-162 (page 8) to reflect this addition. We have also 
expanded the explanation of the observed heterogeneity in section 4.1, line 408 - 415 (page 19) 
of the manuscript. 
We have revised including a statement to indicate that our finding was higher than reported by 
previous studies but showed a consistent pattern that depression and anxiety were highly 









This paper synthesizes existing data concerning the prevalence of mental disorders in Uganda, using 
meta-analytical methods. The topic is highly relevant to the Journal. Although reporting on prevalence 
rates of mental disorders is not new, I agree with the authors that data about the prevalence of mental 
disorders are a starting point to improve public mental health. There are many reasons why findings 
from countries such as Uganda may differ from places that have been studied in much more detail 
before. The paper is well written and the data clearly presented. I have a number of concerns and 
questions. 
Response: We thank the reviewer for these comments 
1. Given the relatively simple and descriptive research question, the paper seems overly long. All sections 
could be considerably shortened without losing the essential information or clarity. 
Response:  We appreciate the reviewer’s comment regarding the length of the manuscript. To 
maintain accurate and complete reporting and adhere in full to PRISMA reporting guidelines and 
promote transparency and reproducibility, we do feel that the current presentation is required to 
do the work justice. The manuscript has been revised and words/sentences in some sections 
have been deleted. 
2. In the introduction very little is said about differences that one might expect between data from Uganda, 
as compared to other places in the world. 
Response: The Background section has been revised to include statements regarding what one 
may expect about prevalence of mental disorders in Uganda: Section 3.1, line 75-76, 78 - 80 
(page 4) of the manuscript. 
3. The authors chose a tight timeframe for their inclusion of studies (2010-2018) – why was that? 
Response: The primary intention of the study was to establish a relatively recent picture of mental 
disorders in Uganda rather than establish long term trends/changes. We have added a word 
‘recent’ to a sentence in the Methods Section 3.2 of the manuscript, line 107-108 (page 5). 
4. I like the systematic and quantitative approach taken to the inevitable heterogeneity in the findings of 
the reviewed existing studies. However, very little conclusion has come of this. This is no fault of the 
authors, but it quite severely restricts the relevance of the paper. 
Response: It is true that the heterogeneity in this review is substantial. We have explored the 





Notwithstanding the heterogeneity, the results suggests high prevalence of depression and 
anxiety disorders in both children and adults in Uganda. The review findings should stimulate 
interest to scale-up public health interventions aimed at minimizing burden associated with such 
disorders and further research to provide a stronger conclusion. 
5. In most previous work, there is quite a large difference in prevalence estimates found, when using 
either more formal diagnostic instruments (such as the MINI or the CIDI) and symptom rating scales with 
cut-off points (such as PHQ). Diagnostic instruments are usually more selective before counting a 
symptom as a true symptom for a psychiatric disorder and therefore mostly yield lower prevalence rates. 
It is surprising and may also be worrying that such differences were not found here. Were these 
instruments properly employed? 
Response: We believe that the instruments were to a large extent used correctly. During 
methodological quality assessment of studies, two questions Q6 and Q7 (see manuscript Table 
3.2) were used to ascertain validity of instrument and reliability of its use to collect data. All studies 
met criterion Q6 validity of instruments, an indication that the instruments were validated and are 
therefore valid to assess specific mental disorder within Uganda cultural context.  However, for 
Q7 that focussed on reliability of data collection, 70% of the studies had evidence to indicate that 
this criterion was satisfied. The remaining 30% were unclear regarding consistent and unbiased 
data collection. This criterion (Q7) was assessed by an explicit, documented evidence that data 
collectors were trained in the use of the instrument or had clinical or research experience in 
psychiatric discipline to ensure reliability of assessment of a mental disorder. Of interest though 
and perhaps a possible explanation of similarities in the result is that MINI was used as the gold 
standard to validate PHQ-9 and HSCL-25 depression module. 
6. On pg 13 it is reported that the lifetime prevalence rates for depression were lower than the point 
prevalence. This seems illogical. 
Response: We agree with the reviewer that the lifetime prevalence of depressive disorders in 
the present review are difficult to reconcile. This may be due to the data ultimately being available 
– 19 studies (involving 13,390 participants) reported current prevalence; of these, only two 
(involving 900 participants) also reported lifetime prevalence. The variability across the studies 
that only reported point prevalence overrode the differences seen in lifetime prevalence alone 
(see below). 
7. In studies of prevalence of mental disorders, the time frame employed is important. Especially in 





rates than point prevalence rates. This indeed is what is usually found. It seems worrying again that the 
differences reported here were small. 
Response:  As mentioned in our response to 6 above, most studies included in the review did 
not assess lifetime prevalence of reported mental disorders. We examined the two studies that 
provided both current and lifetime prevalence of major depressive disorders to better understand 
the pattern. It was clear that the lifetime prevalence of depression in adults (19.4%) was much 
higher than current prevalence (12.8%). We have therefore added a sentence to clarify this 
finding in Section 3.3.6 line 298 - 304 (page 14) of the manuscript. 
8. Similarly, usually the rates of common mental disorders increase as the filters that are inherent in any 
health service are passed. One would expect higher rates of mental problems in health care settings than 
in the community, especially so in LMIC. This was not found. Of course, the authors cannot change the 
findings of the studies they have reviewed, but they could discuss these findings in a more critical way. 
Response: We thank the reviewer for the insightful comments and suggestion. Looking at the 
profile of the population studied (Table 3.1) in Section 3.3.2 of the manuscript, the similarity of 
prevalence of mental disorders between the participants sampled from the health facility and 
community setting may be expected. These may be because most participants sampled from the 
health care setting were mainly outpatient attendees and therefore could have had closer 
commonality with those from the community. The only exception to outpatients was in a study by 
Ashaba et al., 2015 who assessed depression among two groups of patient’s attendants. It is 
also worth noting here that family support and their physical presence during the whole length of 
hospital stay in Uganda may positively assist in reducing the psychological trigger of a mental 
disorder.  
A sentence is added in Section 3.4 line 376 - 380 (page 18) of the manuscript to acknowledge 
the observed pattern of prevalence rate of mental disorders derived from health facilities and 
community settings in Uganda. 
 10. The exposure to known risk factors for mental disorders and their association with disorders is - for 
many purposes - more interesting than the prevalence estimates per se. Can they make more of this? 
Response: Presentation of factors associated with prevalence of mental disorders qualitatively 
derived from primary studies are included in Section 3.4 line 383-388 (page 18) of the manuscript. 
The most common correlates of mental disorders reported by included studies include the 





insecurity among women and living arrangements, particularly for children, among others, were 
reported as major attributors to anxiety and depressive disorders in Uganda. 
11. Comparing the outcomes of the available studies with findings from other countries is hampered by 
the fact that the reviewed studies are limited to depression and anxiety. Although the authors mention 
this, they have not estimated what the effect might have been on the overall prevalence. This is likely 
considerable: if only data on substance abuse were added, the overall rates would likely have increased 
substantially.  
Response: We agree. The pooled prevalence was limited by paucity of a range of mental 
disorders data, in addition to the lack of any large-scale population-based studies. We have 
incorporated a suggestion for future reviews to consider a wider range of mental and substance 




Chapter 4 Discussion and summary 
The previous chapter presents the systematic review of the prevalence of mental disorders among 
children and adults in Uganda. In Chapter 1, literature regarding mental disorders was examined. This 
chapter summarises issues relating to the key findings and their implications for policy, practice and 
research. 
4.1 Summary of research findings 
The results of the research presented in this thesis provide, for the first time, a consolidated prevalence 
estimate of mental disorders in children and adults in Uganda. The prevalence estimates show mental 
disorders are common in Uganda. About 229 per 1,000 children and adolescents were reported to have 
current depressive disorders and anxiety disorders. Similar patterns were revealed for adults 18 years or 
older, where an estimated 242 per 1,000 adults were reported with current and lifetime mental disorders. 
These results, from the systematic review and meta-analysis presented in Chapter 3, were based 
exclusively on 24 unique studies reporting the prevalence of mental disorders conducted in Uganda, 
conducted and published between 2010 and 2018 inclusive. Using transparent, internationally accepted 
processes developed by GRADE (see Section 3.4) allowed for a claim of moderate certainty of the true 
prevalence of mental disorders in Uganda which is likely to be close to the estimate presented by this 
research. 
These results contribute to the understanding of the epidemiology of mental disorders, specifically 
prevalence data in Uganda. Prevalence data is even more important in this era, following the advent of 
the GBD, in which population health status is judged by not only death statistics but also disability.23 The 
basis of this research rested on the lack of knowledge about the prevalence of mental disorders in 
Uganda, like many LMICs.29,30 The high prevalence of depressive and anxiety disorders in children and 
adults presents public health, social and economic challenges for the Uganda population. There is 
considerable evidence in the literature that these two categories of mental disorders are more prevalent 
forms of mental disorders in the general population worldwide.24,25,59,162 
4.1.1 Prevalence of specific mental disorders  
Although it is clear from the existing literature that mental disorders encompass a wide range of emotional 
and behavioural conditions described in the ICD and DSM,14,15 the results of this review suggest that 
MDD and PTSD are the most common disorders affecting children and adults in Uganda. Results from a 






Data on other specific mental disorders with onset in childhood, including schizophrenia, predetermined 
at the outset of the review (see Chapter 2) was generally lacking.163 For example, evidence from the 
literature suggests that the median point prevalence of schizophrenia is 4.6 per 1,000, with a lifetime 
prevalence of 7.2 per 1,000 persons.81,100 This was not identified by the current study. Notwithstanding 
the exclusion of neurological disorders such as ADHD among children, epilepsy and substance use 
disorders, that tend to coexist with anxiety and depressive disorders.105 That lack of prevalence data for 
other mental disorders may not indicate their absence in the Uganda population. However, the high 
prevalence of the two major mental disorders revealed by this research is striking, despite both anxiety 
and depression being known to be highly prevalent and the leading cause of YLDs globally.24,25,134,162 
4.1.2 Assessment of mental disorders 
Epidemiological studies of mental disorders in the past have documented complexities in conceptualising 
and investigating the influence of measures used to obtain prevalence estimates (see Chapter 1).76 The 
number of instruments developed for the assessment of mental disorders in children, adolescents and 
adults has considerably increased in recent years.69,79 Some of the challenges in this research were 
drawing estimates from heterogeneous studies and the range of instruments used to assess mental 
disorders,61 as described in Chapter 3, Section 3.3.2. Although there is ongoing debate on the 
effectiveness of screening and diagnostic instruments and their influence on the diagnosis of mental 
disorders,73 there is evidence that both are appropriate for obtaining prevalence information and providing 
an indication of service needs.75,76 However, the use of these two sets of instruments restricts 
comparability of prevalence estimates from the current research with past epidemiological systematic 
reviews that were based on diagnostic instruments or separate analyses of studies using diagnostic and 
screening instruments.59,82 
Regardless of these conceptual issues surrounding measurement, there are important findings of the 
present research that are worth noting. In most studies from which data was extracted, the diagnostic 
criteria were mapped to DSM-IV and not based on consensus or expert opinion, therefore enabling the 
generation of valid prevalence estimates.17,56 The need for validating screening or diagnostic instruments 
to measure mental disorders in the context of research for obtaining valid and reliable prevalence data 
has been emphasised.74,76 This was an important element in this review (Chapter 2, Section 2.3.2).163 
Indeed, all the included studies used validated instruments; those that used screening instruments 
reported MINI62 as a gold standard used for its calibration (validation). On the other hand, only MINI was 
used by studies that employed diagnostic interviews. Despite this, studies that employed MINI applied a 





instrument (MINI) for those who met certain criteria. This process did not appear to yield substantially 
different prevalence estimates than studies using screening instruments alone. Analysis of whether 
different instruments used had any bearing on the prevalence reported in the available research did not 
provide a clear picture. The similarity in prevalence obtained through diagnostic interviews and use of 
symptom checklists could be reinforced by validation of screening instruments using MINI in these 
studies. 
4.1.3 Current, period, and lifetime prevalence of mental disorders 
Past research shows that the prevalence of depression and anxiety disorders is influenced by the period 
over which it is assessed.72,82 The prevalence estimates of mental disorders presented in this thesis were 
based on current (point) prevalence at the time of the conduct of the study, while 12-month prevalence 
and lifetime prevalence were less frequently reported. The results of lifetime prevalence estimates of 
MDD in this research at face value appeared lower than usually reported in previous studies. Research 
has demonstrated that the lifetime prevalence of mental disorders is often much higher, often double the 
current or point prevalence.59,72,82 In the current research, there was insufficient data from which any 
realistic judgement could be made. This discrepancy found by this research could be explained by the 
variability in the number of studies and sample size. However, it must be acknowledged that lifetime 
prevalence has a potential problem with precision associated with respondent recall accuracy.83 However, 
research suggests that shorter periods prevent recall bias and are more likely to provide a valid 
prevalence estimate than 12-month and lifetime prevalence of mental disorders.59 
4.1.4 Comorbidity 
Depression and anxiety disorders have been documented to be comorbid with other forms of mental 
disorders and in people experiencing a physical illness (see Chapter 1).101,103,105,106 Detailed examination 
of comorbidity was beyond the scope of the current research and hence was not analysed. However, it is 
apparent from the included studies that co-occurrence of depression and anxiety disorders was common. 
In addition, the prevalence of MDD among stroke survivors, people with diabetes and HIV positive 
individuals was high (see Table 3.1 in Chapter 3). This appears to support the claim that there can be ‘no 
health without mental health, further justifying the need for action in this area.28 The concern for 
comorbidity therefore warrants future consideration. It is important to mention here that the somatic 
symptoms of depression and anxiety disorders, as described in ICD-1014 and DSM-5,15 mirror many of 







4.1.5 Associated factors and consequences 
The factors associated with mental disorders (see Chapter 1) present complex challenges and there are 
no clear-cut boundary between triggers and consequences that are mediated by separate events and 
occur over prolonged periods. An analysis of the determinants and consequences of mental disorders 
was not undertaken in this study. 
The review findings in Chapter 3 (Section 3.3) suggest that anyone can develop mental disorders, 
regardless of age. The fact that children in the study were reported to have nearly a similar extent of 
mental disorders as adults is not unusual. Previous studies have shown that mental disorders have an 
early age of onset,79,89,90 and can continue into adulthood, with a later age of onset associated with 
comorbid conditions. 90 Previous research have also reported a higher burden of mental disorders in 
young people aged 10 to 29 years,25 particularly,  with MDD and anxiety disorders.24,25 This is particularly 
important in the Ugandan context where the demographic profile indicates a high proportion of  under 
30s.88 
The high prevalence revealed by the current research points to important implications for children’s and 
young persons’ physiological, personal and social development. Childhood and young adulthood are 
considered critical periods in the life course of an individual whereby they are learning social and 
functioning skills, receiving education, starting work or negotiating independent living.35 Research has 
demonstrated that mental disorders developed during childhood or as young adulthood can have long-
term negative consequences for individuals’ health and other areas of functioning.16 For example, it has 
been documented that people who have mental disorders have a shorter life expectancy, mainly due to 
the comorbid nature of these disorders.31,106 Similarly, a study in Ethiopia reported that people with mental 
disorders were found to die 30 years prematurely than the general population due to infectious diseases 
and suicides.33 Moreover, mental disorders have been shown to worsen physical illnesses and quality of 
life.39 
Explorations of factors associated with mental disorders from the primary research reviewed also 
revealed the coexistence of a number of social factors. Of interest were factors such as living 
arrangements (living with single parents, grandparents, number of siblings) and household poverty, which 
were reported to increase the risk of developing depression among participants studied. Similar factors 
have been documented by research as determinants of mental disorders.123,126 Social factors like these 
are significant in the context of the demographic profile of Uganda, as reported in the National Population 
and Household Census 2014.88 Depression and anxiety among young people have also been implicated 





with mental disorders, including MDD, bipolar disorder and anxiety disorders drop out of school early.38 
The majority of the participants represented in the current research were from those from rural settings, 
peasant farmers, small business owners and fishermen; most had no or lower than high school education. 
Similarly, the effects of depression and anxiety disorders on employment opportunities have been shown 
to be significant (see Chapter 1).44,45 This research did not explore these aspects, and is unable to provide 
a judgement on whether mental disorders were the cause of or affected by the demographic attributes of 
participants. 
4.2 Implications 
4.2.1 Implications for policy 
Given that the Ugandan national health policies and plans aim to address mental health needs through 
early detection and treatment at all levels of care,149,150 the findings of this research highlight some 
important health policy applications. 
The prevalence of mental disorders in this study highlights its potential impact on people at a young age 
and identifies its potential to disrupt education,38 and social and working life.45 This should provide the 
impetus for the Ugandan government to prioritise investments in improving mental health care across 
sectors. This could be achieved by inclusion of strategies aimed at identifying and reducing risk factors 
as well as factors that trigger or promote a relapse of mental disorders. People with conditions that warrant 
treatment and rehabilitation need unlimited access to the required health care. Similarly, it may be 
essential that the education sector incorporates activities that support mental health, such as mental 
health promotion activities in schools.  According to the Ugandan National Population and Housing 
Census 2014, about 80% of the population are of school-going age at various levels of the education 
system. However, the rate at which children leave school, due to various reasons, increases 
exponentially, with 22% leaving between the age of 13 years and 18 years, and peaking at 53.7 % 
between the age of 15 years and 24 years.88 This is further reflected in educational attainment, with 58% 
having primary level education, 15% O-level, 3% A-level, and 4.3% tertiary level.88 A systematic review 
of universal school mental health programs indicates that such programs enhance mental health 
awareness.116 These include identification and mitigation of potential triggers of mental disorders, such 
as bullying. Introducing mental health first aid training to all teachers so they can recognise symptoms of 
depression and anxiety disorders provide timely support and when necessary these teachers can make 
referrals to appropriate sources of help. 
In studies informing this review, social and household factors have been identified as potential triggers 





household factors such as poverty,120,123 food insecurity,92,129 poor housing,119,120 social support,98 low 
levels of education or literacy,123,127 conflicts, verbal/physical abuse or violence,42 broken families, 123 
among others, have been previously identified by research in a similar vein. Therefore, it is imperative for 
mental health stakeholders to develop and evaluate interventions that address and reduce these factors 
that trigger mental disorders at the individual, household and community level. 
Evidence has documented the potential benefits of improving household subsistence, education, 
transport systems, community cooperation and participation in mental health.120 For example, an 
intervention study evaluating the impact of a comprehensive microfinance intervention on depression 
levels of AIDS-orphaned youth living in poorly resourced and AIDS impacted communities in the 
southwestern district of Uganda found strong support for its potential benefits to mental health.121,122 In 
recent years, Village Savings and Loan Associations (VSLA) has proliferated as an option for providing 
financial services to the rural poor in Uganda and other countries in Africa.164 The VSLA is a self-
sustaining and self-replicating mechanism for access to financial services created by a group of people 
who pool their savings and lend funds, and has been reported to improve access to credit and empower 
poor communities.165 
In addition, engagement with governments and community development sectors to identify common 
triggers and mitigating interventions may be helpful in reducing the number of individuals developing 
mental disorders in the future. Such engagement may be through embedding mental health in all policies 
that provide practical initiatives for all stakeholders to address mental wellbeing. These may include 
strategies to promote social inclusions and improve mental health literacy. 
Furthermore, legislative support to protect people affected by mental disorders is one avenue to mitigate 
some of the direct and indirect impacts of mental disorders at the societal level in support of the proposed 
intervention goals in the WHO Mental Health action Plan 2013-2020.148 However, for these efforts to be 
effective, they need to be supported by  structures to operationalise them. Based on the assumption that 
people in the community are more aware of their members’ life situations, they are best placed to detect 
abnormal, emotional and behavioural changes and triggers. Empowering leadership, establishing 
community structures and providing a mandate to identify, manage or refer mental disorder-related cases 
to appropriate services may prove helpful. 
It is hoped that the results of the research presented in this thesis and greater appreciation of the enormity 
of the issues that it has highlighted will encourage the Ugandan government to increase financial 
investments in mental health services. Most of the Uganda population live in rural areas, many of whom 





care. Improving financial allocations and recruitment of essential health professions to include mental 
health professionals, or training of existing non-specialist health providers to enhance task shifting may 
be helpful. 
4.2.2 Implications for practice 
The results of the research included in this thesis have implications for public health and clinical practice 
in Uganda. Based on data from the WHO Mental Health Atlas 2017,150 it can be assumed that recognition 
and treatment of mental disorders in the community and health facilities are low. Therefore, practitioners 
should attempt to improve identification of mental disorders and their associated factors or determinants 
at all levels of care and manage or refer cases for appropriate care early. This process may include 
screening for mental disorders among patients presenting with chronic health conditions. In addition, 
clients with a complaint about physical health symptoms, who receive a negative test result for a 
commonly known illness with a similar presentation such as malaria, should be assessed further for 
mental disorders, specifically depression and anxiety disorders. There is therefore the need to established 
referral systems that can link people with recognised or suspected symptoms of mental disorders to 
appropriate sources of care. 
4.2.3 Implication for research 
The results of the prevalence of mental disorders in both children and adults from this review are limited 
by sample size, targeted sampling, assessing of other specific mental disorders, and measurement 
instruments used. As documented, the primary goal of research investigating the epidemiology of mental 
disorders informed the choice of instruments and types of data collected.61 Therefore the following are 
needed: 
• A countrywide study conducted with adequate sample size to address the current gap. The 
support of the Ministry of Health or Uganda Bureau of Statistics, intergovernmental and non-
government organisations may prove helpful in order to design, organise and finance this 
research. 
• Employing full-length diagnostic interviews to assess or capture more subtypes of mental 
disorders to ensure consistency and more robust data collection. 
• Future research exploring the range of specific mental disorders, such as schizophrenia, eating 
disorders and others with a specific onset in childhood in Uganda. 
• As discussed in Section 3.4, as the determinants or triggers of mental disorders vary, future 





Such research should also consider investigating the comorbidity of mental disorders with other 
physical illnesses. 
• As research from high income countries has highlighted the substantial impact of mental 
disorders (depression and anxiety disorders) on education and economic productivity, research 
(a longitudinal epidemiological study) investigating the association of mental disorders with 
education and social issues such as domestic violence and work among children and adults in 
Uganda. Such evidence can be used to underpin decisions to improve mental health care.  
• Economic evaluation of interventions targeting mental disorders for planning justification and 
improving communications for mental health services. 
• Qualitative research to understand service utilisation to ensure appropriate design of strategies 
that are appropriate, meaningful, feasible and acceptable for users and providers.  
4.3 Conclusion 
The results of the systematic review show that about one in four children and adults in Uganda suffers 
from depression or anxiety disorders. The results presented in this thesis provide a new perspective for 
mental disorders in Uganda that build on existing literature in the field. While prevalence data by itself is 
not sufficient for policy decision making or practice change, it provides an important information to build 
on, such as financial and resources availability, population-level awareness of the problem and coping 
strategies, in order to facilitate better decision-making.80 Further studies are required for bridging these 
gaps, including a nationally designed study to add strength the current review. Owing to the considerable 
contribution of MDD and anxiety to YLDs and premature death, alongside social and economic impacts, 
these disorders warrant specific attention in the health system response. 
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